betamethasone has been researched along with betamethasone-17,21-dipropionate in 472 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 81 (17.16) | 18.7374 |
| 1990's | 66 (13.98) | 18.2507 |
| 2000's | 98 (20.76) | 29.6817 |
| 2010's | 148 (31.36) | 24.3611 |
| 2020's | 79 (16.74) | 2.80 |
| Authors | Studies |
|---|---|
| Jurs, PC; Stouch, TR | 1 |
| Bodor, N; Harget, AJ; Phillips, EW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lassus, A | 1 |
| Leer, JA | 2 |
| Evans, CD; Flatman, CJ; Northway, CS; Strand, LJ | 1 |
| Charney, P; Superfon, N | 1 |
| Fedi, AM; Leoncini, P; Lotti, T; Meo, AL; Rizzo, A | 1 |
| Lacour, JP; Le Fichoux, Y; Ortonne, JP; Vitetta, A | 1 |
| Hägermark, O; Wahlgren, CF | 1 |
| Bohan, DF; Caruana, C; Francom, SF; Holland, M; Hughes, GS; Means, LK | 1 |
| Krueger, GG; Pershing, LK; Shah, VP; Silver, BS; Skelley, JP | 1 |
| Basta-Juzbasić, A; Dobrić, I; Mustac-Gotovac, M; Paljan, D; Pasić, A | 1 |
| Breneman, DL; Dromgoole, SH; Griffith, RF; Hebert, AA; Hickman, JG; Maloney, JM; Millikan, LE; Sefton, J; Smith, EB; Sulica, VI | 1 |
| Korsukewitz, G; Mensing, H; Yawalkar, S | 1 |
| Schwerzmann, L; Yawalkar, SJ | 1 |
| Cains, GD; Gilmore, SJ; Kelly, JW; Rallings, M | 1 |
| Jones, ML; Katz, HI; Krueger, GG; Medansky, RS; Mooney, JJ; Prawer, SE; Samson, CR | 1 |
| Hessel, A; Zyniewicz, K | 1 |
| Boiko, S; Lucky, AW; Reynolds, RD | 1 |
| Fox, K; Guzzo, C; Lavker, R; Lazarus, G; Roberts, LJ; Schechter, N | 1 |
| Olsen, EA | 1 |
| Saurat, JH; Schmied, C | 1 |
| Braun-Falco, O; Korting, HC; Schäfer-Korting, M; Zienicke, H | 1 |
| Kaukhova, OIa; Kubanov, AA; Shakhtmeĭster, IIa; Skripkin, IuK | 1 |
| Miki, Y; Shiraishi, S; Takemiya, M | 1 |
| Mahrle, G; Schulze, HJ | 1 |
| Camacho, F; García-Bravo, B; Mazuecos Blanca, J; Moreno Giménez, JC; Sotillo, I | 1 |
| Ellis, CN; Goldfarb, MT; Gupta, AK; Hamilton, TA; Voorhees, JJ | 1 |
| Katz, HI; Prawer, SE | 1 |
| Bachelet, CM; Bernaudin, JF; Fleury-Feith, J | 1 |
| Jaeger, L | 1 |
| Bauer, FW; Boezeman, JB; de Grood, RM; Rijzewijk, JJ | 1 |
| Ballesteros, F; Gordillo, E; Gordillo, H; Saffie, F | 1 |
| Andersson, PH; Brattsand, R; Thalén, A | 1 |
| Chuang, TY; Samson, CR | 1 |
| Katz, HI; Mooney, JJ; Prawer, SE; Samson, CR | 1 |
| Lildholdt, T | 1 |
| Bunker, CB; Dowd, PM; English, JS; Greaves, MW; Ruthven, K | 1 |
| Puissegur Lupo, ML | 1 |
| Nolting, S | 1 |
| Gonçalo, M; Gonçalo, S; Moreno, A | 1 |
| Anand, S; Arora, PN; Chattopadhyay, SP; Sharma, SD | 1 |
| Bianchi, O; Bonino, MV; Galimberti, RL; Garcia Garcia, A; Kowalczuk, AM | 1 |
| Caldwell, DR; Centifanto, YM; Yates, F | 1 |
| Johannesson, A; Lindelöf, B | 2 |
| Faurschou, P; Laursen, LC; Munch, EP | 1 |
| Casanova, JM; Cortada, L; Puig, T; Ramos, J; Rubio, M | 1 |
| Kaukhova, OIa; Kunin, NA; Pisarenko, MF; Pokryshkin, VI; Shakhtmeĭster, IIa | 1 |
| Cornell, RC; Jacobson, C; Savin, RC | 1 |
| Cornell, RC; Olsen, EA | 1 |
| Hien, NT; Katz, HI; Mastbaum, LI; Mooney, JJ; Prawer, SE; Samson, CR | 1 |
| Barkey, WF | 1 |
| Grivna, EM; Hien, NT; Katz, HI; Prawer, SE; Scott, JC | 1 |
| Clark, L; Krueger, GG; McBride, PT | 1 |
| Guzzo, C; Lavker, RM; Lazarus, GS; Schechter, NM | 1 |
| Jacobs, PH | 1 |
| Hood, AF; Katz, R | 1 |
| Karlsmark, T; Verdich, J | 1 |
| Hirota, S; Morita, M | 1 |
| Gaillard, RC; Poffet, D; Riondel, AM; Saurat, JH | 1 |
| Barton, J; Lavker, RM; Lazarus, GS; Schechter, NM | 1 |
| Osbourn, RA | 1 |
| Malmsten, LA; Scott, M; Thelin, I | 1 |
| Lassus, A; Salde, L | 1 |
| Hagemeier, HH; Nolting, S | 1 |
| Baer, RL; Belsito, DV; Gigli, I; Thorbecke, GJ | 1 |
| Fukiishi, Y; Hasegawa, Y; Mizushima, Y; Yoshida, T | 1 |
| Macarol, V; Schindléry, C; Weitgasser, H | 1 |
| Dressler, H; Schuppli, R; Weirich, EG; Yawalkar, SJ | 1 |
| Aso, M; Shimao, S | 1 |
| Harms, M; Konzelmann, M | 1 |
| Rhodes, EL; Scott, LV | 1 |
| Bakkers, EJ; Go, MJ; Montnor, LP; Roessel, FE; van der Wateren, AR; van Dijk, E; Wuite, J | 1 |
| Gärtner, L; Tarras-Wahlberg, C | 1 |
| Gip, L; Hamfelt, A | 1 |
| Blum, G; Kröpfli, P; Küng, D; Suter, H | 1 |
| Bard, J; Cole, GW; Fischer, S; Katz, HI; McCormick, GE; Medansky, RS; Nesbitt, LT; Rex, IH | 1 |
| Baer, RL; Belsito, DV; Flotte, TJ; Gigli, I; Lim, HW; Thorbecke, GJ | 1 |
| Crijns, MB; Nater, JP; van der Valk, PG; van Oostveen, F | 1 |
| Pommarede, R; Queille, C; Saurat, JH | 1 |
| Bonerandi, JJ; Pascal, J; Roagna, C | 1 |
| Lodolo, JC | 1 |
| Cabrera, ME | 1 |
| Fredriksson, T; Salde, L | 1 |
| Wortzel, MH | 1 |
| Malfitan, VA | 1 |
| Durocher, LP; Elie, R; Kavalec, EC | 1 |
| Lane, AT; Wachs, GN; Weston, WL | 1 |
| Beck, M; Berger, C; Filipp, N; Hundertmark, U; Loewel, R | 1 |
| Høvding, G | 1 |
| Leibsohn, E | 1 |
| Hillström, L; Pettersson, L; Svensson, L | 1 |
| Doteuchi, M; Nakano, M; Nishiuchi, M; Takashima, A; Takeuchi, M; Yamada, H | 1 |
| Nakano, M; Nishiuchi, M; Takeuchi, M; Yamada, H | 1 |
| Besson-Léaud, M; Dandine, M; Lavaud, J; Limal, JM | 1 |
| Nakano, M; Sugeno, K; Takeuchi, M | 1 |
| Gutierrez Aldana, G | 1 |
| Downie, DA; Salmon, RM; Swarbrick, PT | 1 |
| De Natale, G; Preziosi, P; Vacca, M | 1 |
| Fischer, GO | 1 |
| Bos, JD; Brakman, M; Spuls, PI; Westerhof, W | 1 |
| Elewski, BE; Rosen, T | 1 |
| Ameglio, F; Bonifati, C; Fazio, M; Pietravalle, M | 1 |
| Moores, WB; Shelley, ED; Smith, SS; Talanin, NY | 1 |
| Arbiser, JL; Arndt, KA; Grossman, K; Kaye, E | 1 |
| Lambert, L; Pershing, LK; Shah, VP; Williams, RL; Wright, ED | 1 |
| Scarpa, C | 1 |
| Baxter, ML; Gupta, AK; Lester, RS; Sauder, DN; Shear, NH | 1 |
| Bjerring, P | 1 |
| Aeling, JL; Huff, L; Walsh, P; Weston, WL | 1 |
| David, M; Hodak, E; Neeman, A; Sandbank, M; Trattner, A | 1 |
| Jondreau, L; Kenny, C; Shupack, JL; Stiller, MJ | 1 |
| Moriello, KA; Ridgway, HB | 1 |
| Clever, D; Franson, RC; Ghosh, S; Nair, X; Nettleton, D; Tramposch, KM | 1 |
| Roberts, DT | 1 |
| Delescluse, J; van der Endt, JD | 1 |
| Bayle-Lebey, P; Bazex, J; Loche, F; Marguery, MC; Raynal, H | 1 |
| Eubanks, LE; Galen, W; McBurney, EI; Reed, R | 1 |
| Nielsen, NH; Petersen, CS | 1 |
| Finkel, LJ; Griffiths, CE; Hamilton, TA; McMichael, AJ; Rafal, ES; Talwar, HS; Voorhees, JJ | 1 |
| Eriksson, E; Erkko, P; Granlund, H; Reitamo, S | 1 |
| Singh, S | 1 |
| Iida, T; Muramatsu, T; Shirai, T | 1 |
| Erkko, P; Granlund, H; Reitamo, S | 1 |
| Green, C | 1 |
| Haustein, UF; Nenoff, P | 1 |
| Ikuse, T; Sawa, K; Shirasawa, E; Tsuji, F | 1 |
| Gilbertson, EO; Mulford, MI; Piacquadio, DJ; Spellman, MC | 1 |
| Shah, VP; Varsano, J; Zatz, JL | 1 |
| Kuo, KW; Lee, JY; Sheu, HM; Tsai, JC | 1 |
| Feldman, SR; Fleischer, AB; Smith, ES | 1 |
| Gianotto, EA; Kedor-Hackmann, ER; Santoro, MI | 1 |
| Gutierrez-Ureña, S; Ramos-Remus, C | 1 |
| Garzon, MC; Paller, AS | 1 |
| Kaliuzhnaia, DD | 1 |
| Labrèze, C; Marlière, V; Roul, S; Taïeb, A | 1 |
| Elkins, JS; Shah, VP; Williams, RL | 1 |
| Guzzo, C; Margolis, D; Miller, JJ; Roling, D | 1 |
| Feldman, SR; Fleischer, AB | 1 |
| Agius, A; Borg, E; Pace, JL | 1 |
| Detweiler, JG; Glass, M; Lorenzana, ER; Rees, TD | 1 |
| Lin, M; Wu, N | 1 |
| MacGregor, EG; Perini, L; Villalobos, R | 1 |
| Hecker, D; Lebwohl, M; Worsley, J; Yueh, G | 1 |
| Pandey, SS; Reddy, DC; Singh, S | 1 |
| Feldman, SR; Fleischer, AB; Shaffer, MP | 1 |
| Desai, A; Janaki, VR; Mittal, RR; Savant, S; Sengupta, S | 1 |
| Meires, J; Ober, V | 1 |
| Armingaud, P; Estève, E; Normand, F | 1 |
| Bélaïch, S; Bodak, N; Crickx, B; Descamps, V; Grossin, M; Lebrun-Vignes, B; Valeyrie, L | 1 |
| Gregurek-Novak, T | 1 |
| Dan, M | 1 |
| Emgård, P; Hellström, S | 2 |
| van de Kerkhof, PC; van Erp, PE; van Rossum, MM | 1 |
| Bibby, AJ; Buckley, C; Decroix, J; Douglas, WS; Gulliver, W; Iglesias, L; Krogstad, AL; Larsen, FG; Mrowietz, U; Ortonne, JP; Poulin, Y | 1 |
| Bibby, AJ; Bissonnette, R; Cambazard, F; Chu, AC; Decroix, J; Douglas, WS; Kaufmann, R; Lowson, D; Mascaro, JM; Murphy, GM; Stymne, B | 1 |
| Alston, SJ; Braun, M; Cohen, BA | 1 |
| Etoh, T; Kanou, S; Kariya, S; Kim, S; Matsumoto, M; Nakai, T; Ohsawa, K; Ohtani, M; Uchino, K | 1 |
| Boyden, B; Burg, G; Chu, A; Guenther, L; Guilhou, JJ; Hanssen, LI; Harvima, RJ; Kaufmann, R; Larsen, FG; Papp, KA; Rogers, S; Talbot, D; Tegner, E; van de Kerkhof, PC | 1 |
| Chamberlain, AJ; Tam, MM | 1 |
| Lim, DS; Triscott, J | 1 |
| Camarasa, JM; Dubertret, L; Ortonne, JP | 1 |
| Balducci, A; Casadio, C; Farina, P; Mancuso, G; Milani, M; Staffa, M; Valenti, L | 1 |
| Gautier, JF; Lubin, V; Sobngwi, E; Timsit, FJ; Ury, P; Vexiau, P | 1 |
| Hughes-Formella, BJ; Traulsen, J | 1 |
| ROSSET, M; SCHACHTER, RK; STEINBERG, S | 1 |
| CASTILLO, FJ; CUEVA, J | 1 |
| Lui, H; Shapiro, J | 1 |
| Fletcher, A; Keegel, T; Milne, R; Nixon, R; Sajjachareonpong, P; Saunders, H | 1 |
| Garrott, HM; Walland, MJ | 1 |
| Balkrishnan, R; Cook, JM; Feldman, SR; Fleischer, AB; Saltzberg, FB; Shaffer, MP | 1 |
| Guenther, LC | 2 |
| Estebaranz, JL; Fleming, C; Hanssen, LI; Kragballe, K; Lui, H; Noerrelund, KL; Ortonne, JP; Persson, LM; Uurasmaa, T; Wozel, G | 1 |
| Traulsen, J | 1 |
| van de Kerkhof, PC | 2 |
| HECHT, RA | 1 |
| Fukagawa, S; Furue, M; Koga, T; Nakahara, T; Uchi, H | 1 |
| Bugakova, TM; Pronina, IuV; Vakhrushev, SG; Zyrianov, MM | 1 |
| Goodfield, M; Kaufmann, R; Lecha, M; Ortonne, JP | 1 |
| Darley, CR; Hawk, JL; Sahni, D | 1 |
| Flagothier, C; Piérard, GE; Piérard-Franchimont, C; Uhoda, I | 1 |
| Didriksen, E; Hansen, J; Høy, G; Melchior, N; Persson, J; Simonsen, L | 1 |
| Fenton, C; Plosker, GL | 1 |
| Frieden, IJ; Garzon, MC; Hawrot, A; Lucky, AW | 1 |
| Lin, GY; Lin, JJ; Shih, C; Yueh, KC | 1 |
| Mohammad, Ael-N | 1 |
| Edwards, NA; Hackett, LP; James, R; Quigley, P | 1 |
| Emgård, P; Hellström, S; Holm, S | 1 |
| Cambazard, F; Kragballe, K; Murray, S; van de Kerkhof, PC; Wasel, N | 1 |
| Guignard, E; Ortonne, JP; Peeters, P; Sitbon, R | 1 |
| Meaume, S | 1 |
| Delvoye, P; Flagothier, C; Henry, F; Piérard, GE; Piérard-Franchimont, C | 1 |
| Chrysomallis, F; Kastanis, A; Lazaridou, E; Loannides, D; Vakirlis, E | 1 |
| Kragballe, K; van de Kerkhof, PC | 1 |
| Kaur, I; Kumar, B; Kumaran, MS | 1 |
| Charakida, A; Charakida, M; Chu, AC; Dadzie, O; Evangelou, G; Teixeira, F | 1 |
| Downs, AM | 1 |
| Flagothier, C; Henry, F; Piérard, GE; Piérard-Franchimont, C | 1 |
| Austad, J; Barnes, L; Bibby, A; Cambazard, F; de la Brassinne, M; Fleming, C; Heikkilä, H; Jolliffe, D; Kragballe, K; Peyri, J; Svensson, A; Toole, J; Wozel, G | 1 |
| Bibby, A; Cambazard, F; Foster, R; Haverkamp, C; Martinez Escribano, JA; Naeyaert, JM; Thaçi, D; Vender, R; White, S | 1 |
| Adriaans, B; Fergusson-Wood, LA; Griffiths, MR; Porter, W | 1 |
| Anstey, AV; Kragballe, K | 1 |
| Chen, W; Hung, CL; Liao, CY; Lin, TK; Sheu, HM; Zouboulis, CC | 1 |
| Austad, J; Barnes, L; Bibby, A; Cambazard, F; de la Brassinne, M; Fleming, C; Heikkilä, H; Kragballe, K; Peyri Rey, J; Svensson, A; Toole, J; Williams, Z; Wozel, G | 1 |
| Bovenschen, HJ; de Jong, EM; Gerritsen, WJ; Seyger, MM; van de Kerkhof, PC; van Rens, DW | 1 |
| Bellino, M; Cassano, N; Coviello, C; Loconsole, F; Miracapillo, A; Vena, GA | 1 |
| Gramp, A; Pearce, A; Reid, C; Sidhu, S | 1 |
| Cassano, N; Vena, GA | 1 |
| Kragballe, K; Mrowietz, U; Segaert, S; van de Kerkhof, PC | 1 |
| Barankin, B; Ting, P | 1 |
| Bovenschen, HJ; Erceg, A; Seyger, MM; Van De Kerkhof, PC; Van Vlijmen-Willems, I | 1 |
| Lebwohl, MG | 1 |
| Arimura, A; Deguchi, M; Haruna, T; Iduhara, M; Takahashi, H; Takaki, S; Yamamoto, M; Yasui, K | 1 |
| Cary-Ten Have Dallinga, M; El Kouri, C; Lortholary, A; Morineau, N; Ramée, JF | 1 |
| Dytoc, MT; Kossintseva, I; Ting, PT | 1 |
| Auland, ME; Bottomley, JM; Boyd, G; Douglas, WS; Morais, J | 1 |
| Azevedo, F; Lima, M; Lisboa, C; Moreira, E; Príncipe, F | 1 |
| Gurevitch, B; Klein, M; Rozentsveig, V; Rudich, T; Semionov, M; Velan, GJ; Weksler, N | 1 |
| Bouassida, S; Boudaya, S; Dammak, A; Marrekchi, S; Masmoudi, A; Turki, H | 1 |
| Buckley, C; Cambazard, F; Hoffmann, V; Milsgaard, M; Saari, S; Shapiro, J | 1 |
| Chen, CY; Chen, YH; Lo, PY; Tzung, TY; Yang, CY | 1 |
| Austad, J; Berne, B; Burden, AD; de Unamuno, P; Figueiredo, A; Ganslandt, C; Jemec, GB; Ortonne, JP; Poulin, Y | 1 |
| Bourcier, M; Cambazard, F; Clonier, F; Gupta, G; Kidson, P; Larsen, FG; Luger, TA; Shear, NH | 1 |
| Degirmenci, E; Dogan, S; Erdogmus, B; Yazici, B; Yucel, I | 1 |
| Frank, J; Poblete-Gutierrez, P; Sterneberg-Vos, H; van Marion, AM | 1 |
| Anstey, A; Barnes, L; Bolduc, C; Hoffmann, V; Reich, K; Saari, S; Segaert, S; Vaillant, L; van de Kerkhof, PC | 1 |
| Abramovits, W; Colón, LE; Gottschalk, RW; Johnson, LA; Menter, A | 1 |
| Avgerinou, G; Belyayeva, H; Daniel Iii, CR; Gregoriou, S; Katsambas, A; Kontochristopoulos, G; Larios, G; Rigopoulos, D; Stamou, C; Verra, P | 1 |
| Orchard, D; Tuxen, AJ | 1 |
| Hoffmann, V; Kragballe, K; Nordin, P; Ortonne, JP; Segaert, S; Tan, J | 1 |
| Buevich, AV; Li, M; Lin, M; Osterman, R; Rustum, AM | 1 |
| Galinada, WA; Markovich, RJ; Rustum, AM; Shou, M; Tang, Q; Wei, YC | 1 |
| Giovannini, A; Girolomoni, G; Gisondi, P; Rosina, P | 1 |
| Abdelouahab, N; Heard, CM; Zulfakar, MH | 1 |
| Dragos, V; Mervic, L; Pavlović, MD | 1 |
| Caddeo, C; Fadda, AM; González-Paredes, A; Manconi, M; Monteoliva-Sánchez, M; Ramos-Cormenzana, A | 1 |
| Benedix, F; Geyer, A; Lichte, V; Metzler, G; Röcken, M; Strölin, A | 1 |
| Porncharoenpong, S; Sookpotarom, P; Vejchapipat, P | 1 |
| Brito, C; da Luz Duarte, M; Pardal, F; Ventura, F; Vilarinho, C | 1 |
| Coquart, N; Karam, A; Metges, JP; Misery, L | 1 |
| Enevold, A; Ganslandt, C; Jemec, GB; van de Kerkhof, PC | 1 |
| Hino, R; Kabashima, R; Kawakami, C; Nakamura, M; Sugita, K; Tokura, Y | 1 |
| Augustin, M; Herberger, K; Kornek, T; Radtke, MA | 1 |
| Mellick, N; Noakes, R | 1 |
| Gill, NL; Johnston, SE; Markovich, R; Rustum, AM; Wei, YC | 1 |
| Appell, M; Bibby, A; Foster, R; Hamilton, T; Lee, M; Mendoza, N; Tyring, S | 1 |
| Higaki, M; Horie, RT; Ishihara, T; Ito, J; Nakagawa, T; Sakamoto, T | 1 |
| de Peuter, R; Jansen, JP; Ryttov, J; van de Kerkhof, P | 1 |
| Freeman, K | 1 |
| Affleck, AG; Auland, M; Bottomley, JM; Jackson, P; Ryttov, J | 1 |
| Bottomley, JM; Ryttov, J; Taylor, RS | 1 |
| Chimenti, S; Gniadecki, R; Goldblum, O; Kupper, H; Ortonne, JP; Reich, K; Sprøgel, P; Thaçi, D; Unnebrink, K | 1 |
| Alex, A; Drexler, W; Heard, CM; Porter, RM; Povazay, B; Thomas, CP; Zulfakar, MH | 1 |
| Compère, P; Ducat, E; Evrard, B; Gillet, A; Hubert, P; Lecomte, F; Piel, G | 1 |
| McCormack, PL | 2 |
| Murphy, G; Reich, K | 1 |
| Le, K; Wood, G | 1 |
| Cassano, N; Galluccio, A; Pezza, M; Vena, GA; Vestita, M | 1 |
| Calzavara-Pinton, P; Rossi, MT; Sala, R; Venturini, M | 1 |
| Kircik, LH | 1 |
| Ahmad, I; Khattak, SU; Qazi, MS; Usmanghani, K | 1 |
| Belo, L; Castro, E; Coimbra, S; Figueiredo, A; Oliveira, H; Quintanilha, A; Reis, F; Rocha, S; Rocha-Pereira, P; Santos-Silva, A; Teixeira, F | 1 |
| Fan, H; He, C; Hu, Q; Tan, J; Yang, K; Zhu, Y; Zou, J | 1 |
| Bhutani, T; Busse, KL; Koo, J; Patel, T | 1 |
| Enevold, A; Ganslandt, C; Hoffmann, V; Queille-Roussel, C | 1 |
| Deshpande, P; Dubey, M; Jain, V; Reddy, S; Singal, AK | 1 |
| Fat, CL; Leslie, T | 1 |
| Newman, MD; Silverberg, NB | 1 |
| Arroja, B; Canhoto, M; Cotrim, I; Gonçalves, C; Silva, F; Vasconcelos, H | 1 |
| Flores, R; Gottlieb, A; Levy, R; Liang, J; Punwani, N; Scherle, P; Shi, J; Williams, W; Yeleswaram, S | 1 |
| Li, W; Man, XY | 1 |
| Bankaoglu, M; Dogu, B; Kuran, B; Sag, SY; Yucel, SD | 1 |
| Fischer, G; Hong, E; Kapila, S | 1 |
| Heard, CM; Ong, CM; Zulfakar, MH | 1 |
| Ayala, F; Cannavò, SP; Chimenti, S; De Pità, O; Girolomoni, G; Peserico, A; Vena, GA | 1 |
| Kossard, S; Lim, PP; Stapleton, K | 1 |
| Cabral, LM; de Almeida Borges, VR; de Sousa, VP; Simon, A | 1 |
| Boyce, BM; Bukhalo, M; Ganslandt, C; Gold, LS; Grekin, S; Kempers, S; Lebwohl, M; Menter, A; Villumsen, J | 1 |
| Hendriks, AG; Hondebrink, E; Seyger, MM; Steenbergen, W; van de Kerkhof, PC; van Hespen, JC | 1 |
| Tsunemi, Y | 1 |
| Calvieri, S; Camplone, G; Chimenti, S; D'Agostino, M; De Simone, C; Di Cesare, A; Filosa, G; Frascione, P; Gabellini, M; Lunghi, F; Mazzotta, A; Peris, K; Saraceno, R; Scotto Di Luzio, G; Simonacci, M | 1 |
| Bachelez, H; Bagot, M; Cavelier-Balloy, B; Dauendorffer, JN | 1 |
| Koh, MJ; Koh, WL; Sim, CS; Tay, YK | 1 |
| Artibani, W; Cerruto, MA; D'Elia, C | 1 |
| Jwa, SW; Kim, BS; Kim, HS; Kim, MB; Ko, HC; Mun, JH; Park, JM; Song, M | 1 |
| Clonier, F; Gupta, AK; Leeder, R; Olesen, M; Silver, S; Taraska, V; Tuppal, R | 1 |
| Ropke, M; Segaert, S | 1 |
| Aragoneses Calvo, A; Gallego Rodriguez, S; Márquez Pardo, R; Martínez Barbeito, MB; Pérez Pelayo, M | 1 |
| Bogdanovska, L; Dimitrovska, A; Petkovska, R; Popovska, M | 1 |
| Chimenti, S; Esposito, M; Frangione, V; Grodzińska, A; Kapińska-Mrowiecka, M; Naldi, L; Ortonne, JP | 1 |
| Hol, CW; Lambert, J; Vink, J | 2 |
| Cassano, N; Neri, L; Vena, GA | 1 |
| de Jong, EM; Mul, K; Oostveen, AM; Seyger, MM; van de Kerkhof, PC; van Geel, MJ | 1 |
| Aberer, W; Böckle, BC; Jara, D; Nindl, W; Sepp, NT | 1 |
| Debarre, JM; Gooderham, M; Goodfield, M; Keddy-Grant, J; Kurvits, M; Xu, Z | 1 |
| Clonier, F; Olesen, M; Queille-Roussel, C | 1 |
| Cantrell, W; Elewski, B; Kole, L | 1 |
| Del Rosso, JQ | 1 |
| de Jong, EM; Donders, AR; Oostveen, AM; Seyger, MM; van de Kerkhof, PC | 1 |
| ALBouzidi, A; Boui, M; Frikh, R; Hjira, N | 1 |
| Bachelez, H; de Jong, EM; Gisondi, P; Mrowietz, U; Puig, L; Reich, K; Warren, RB; Zschocke, I | 1 |
| Hendriks, AG; Joosten, I; Keijsers, RR; Koenen, HJ; van de Kerkhof, PC; van Erp, PE | 1 |
| Altay, MA; Altay, N; Ertürk, C; Kalender, AM; Öztürk, İA | 1 |
| Chen, D; Ma, P; Yang, J; Yu, B; Yuan, L | 1 |
| Molokhova, EI; Sorokina, IuV | 1 |
| Clark, A; Feldman, SR; Harrison, J; Huang, KE; Sandoval, LF | 1 |
| Alajbeg, I; Andabak Rogulj, A; Brkić, D; Džanić, E | 1 |
| Bagel, J; Knuckles, ML; Levi, E; Tyring, S | 1 |
| Glick, BP; Touloei, K; Wiener, A | 1 |
| Lacour, JP; Olesen, M; Queille-Roussel, C; Villumsen, J | 1 |
| Annessi, G; Boccaletti, V; Cortelazzi, C; Di Nuzzo, S; Fabrizi, G; Fantini, C; Feliciani, C; Pagliarello, C; Zampetti, A | 1 |
| Borges, NC; Donato, JL; Moreno, P; Moreno, RA; Oliveira, SE | 1 |
| Cui, P; Facy, P; Gao, T; Ge, M; Gu, J; Hao, F; Kurvits, M; Li, R; Ma, L; Sun, Q; Wang, G; Xu, J; Xu, Z; Yang, H; Yang, Q; Zheng, M | 1 |
| Ali, MA; Birchall, JC; Coulman, SA; Dayan, CM; Hanna, SJ; Tatovic, D; Thrower, SL; Wong, FS | 1 |
| Eimpunth, S; Friedmann, DP; Goldman, MP; Liolios, AM; Wu, DC | 1 |
| Bagel, J; Bruce, S; Koo, J; Olesen, M; Tyring, S; Villumsen, J; Werschler, WP | 1 |
| Bagel, J; Leonardi, C; Olesen, M; Pariser, D; Stein Gold, L; Xu, Z; Yamauchi, P; Østerdal, ML | 1 |
| Gultekin, A; Karahan, AY; Tok, F; Yildirim, A; Yildirim, P | 1 |
| Lovato, P; Norsgaard, H; Røpke, MA; Tokura, Y | 1 |
| Fowler, JF; Hebert, AA; Sugarman, J | 1 |
| Jackson, JM; Knuckles, ML; Stein Gold, L; Weiss, JS | 1 |
| Stein Gold, LF | 1 |
| Fernández-Sánchez, C; Gonzálvo, P; Hidalgo-García, Y; Mallo-García, S | 1 |
| Abdelaleem, Ael-B; Darwish, HW; Elzanfaly, ES; Saad, AS | 1 |
| Da Silva, Cde B; Funk, NL; Guedes, AM; Motta, MH; Tedesco, SB; Visintainer, AP; Weber, J | 1 |
| Bang, B; Cambazard, F; Griffiths, CE; Kalb, RE; Lowson, D; Paul, C; Stein Gold, L | 1 |
| Koo, J; Lebwohl, M; Menter, A; Rosen, M; Stein Gold, L; Villumsen, J | 1 |
| Bagel, J; Leonardi, C; Moller, A; Osterdal, ML; Pariser, D; Stein Gold, L; Xu, Z; Yamauchi, P | 1 |
| Clark, M; Copley-Merriman, C; Gnanasakthy, A; Zelt, S | 1 |
| Frampton, JE; Kim, ES | 1 |
| Yamauchi, P | 1 |
| Clonier, F; Lacour, JP; Nørremark, K; Queille-Roussel, C; Rosen, M | 1 |
| Boden, KT; Seuthe, AM; Szurman, P | 1 |
| Aksoy, C; Aydin, T; Dernek, B; Diracoglu, D; Kesiktas, FN; Koseoglu, PK; Yesilyurt, T | 1 |
| Gold, LS; Lebwohl, M; Leonardi, C; Menter, A; Møller, A; Paul, C; Reich, K; Warren, RB | 1 |
| Bissonnette, R; Dickstein, D; Estrada, YD; Guttman-Yassky, E; Labuda, T; Malik, K; Oliva, M; Peng, X; Suarez-Farinas, M; Suprun, M; Todd, D; Ungar, B; Xu, H | 1 |
| Bachelez, H; de Jong, EMGJ; Gisondi, P; Mrowietz, U; Ortland, C; Puig, L; Reich, K; Warren, RB; Zschocke, I | 1 |
| Bachmeyer, C; Rouff, E | 1 |
| Iizuka, H; Satoh, K; Takagi, A; Takahashi, H | 1 |
| Cakci, A; Gurcay, E; Guzel, S; Ozturk, D; Zeliha Karaahmet, O | 1 |
| Caldarola, G; De Simone, C; Moretta, G; Peris, K; Poscia, A | 1 |
| Balevi, A; Özdemir, M; Ustuner, P | 1 |
| Chantzaras, A; Kontodimas, S; Yfantopoulos, J | 1 |
| Asche, CV; Feldman, SR; Kim, M; Lu, M; Zografos, P | 1 |
| Frieder, J; Kivelevitch, D; Menter, A | 1 |
| Bulai Livideanu, C; Kaldate, R; Paul, C; Røpke, M; Snel, A | 1 |
| Blume-Peytavi, U; Darvin, ME; Jung, S; Kottner, J; Lademann, J; Pedersen, CB; Richter, C; Richter, H; Røpke, MA; Schanzer, S | 1 |
| Goldenberg, G; Hashim, PW; Kircik, LH; Nia, JK; Terrano, D | 1 |
| Cordoba-Guijarro, S; Fernández-Redondo, V; García-Doval, I; Gatica-Ortega, ME; Giménez-Arnau, A; González-Pérez, R; Mercader-García, P; Pastor-Nieto, MA; Serra-Baldrich, E; Silvestre-Salvador, JF | 1 |
| Ikumi, K; Kubo, R; Morita, A; Muramatsu, S; Nishida, E; Sagawa, Y; Saito, C; Torii, K | 1 |
| Foley, P; Garrett, S; Ryttig, L | 1 |
| Andersen, F; Andersen, KE; Andersen, KH; Svendsen, MT | 1 |
| Anger, T; Gerdes, S; Hutt, HJ; Körber, A; Krakor, M | 1 |
| Duarte, B; João, A; Lencastre, A; Ramos Pinheiro, R | 1 |
| Elkady, EF; Hassib, ST; Mahrouse, MA; Sayed, RM | 1 |
| Ariëns, LFM; De Bruin-Weller, MS; Stades, AME; van de Woestijne, AA; van der Schaft, J | 1 |
| Cambazard, F; Griffiths, CE; Kalb, RE; Lowson, D; Møller, A; Paul, C; Stein Gold, L | 1 |
| Carretero, G; Puig, L | 1 |
| Adamski, Z; Bowszyc-Dmochowska, M; Dańczak-Pazdrowska, A; Gaura, T; Olek-Hrab, K; Osmola-Mańkowska, A; Polańska, A; Żaba, R | 1 |
| Bagel, J; Nelson, E; Zapata, J | 1 |
| Cantrell, W; Gooding, K; Gorelick, J; Kucera, K; Veverka, KA | 1 |
| Fang, K; Han, D; Jin, H; Li, S; Liu, Y; Wang, KY; Wang, T; Zhang, S | 1 |
| Gad, S; Ghorab, MM; Hanna, PA | 1 |
| Bewley, AP; Calzavara-Pinton, PG; Hansen, JB; Nyeland, ME; Shear, NH; Signorovitch, J | 1 |
| Andersen, SB; Berg, P; Calzavara-Pinton, PG; de la Cueva Dobao, P; Jalili, A; Jensen, KL; Lebwohl, M; Pink, AE; Segaert, S; Stein Gold, L; Thaçi, D | 1 |
| El-Mosallamy, SS; El-Zeany, BA; Hassan, NY; Merey, HA | 1 |
| Nixon, R; Shen, S; Wong, GN | 1 |
| Duvetorp, A; Engerstedt Mattsson, E; Levin, LÅ; Ryttig, L | 1 |
| Barrick, CJ; Ermolovich, T; Lountzis, NI; Onikoyi, O; Purcell, SM | 1 |
| Balato, A; Caterino, P; Cirillo, T; Dente, V; Gallo, L; Lodi, G; Megna, M; Mozzillo, R | 1 |
| Herbig, ME; Müller-Goymann, CC; Puschmann, J | 1 |
| Berg, P; Calzavara-Pinton, PG; de la Cueva Dobao, P; Jalili, A; Jensen, KL; Pink, AE; Segaert, S; Thaçi, D; Torpet, M | 1 |
| Polcz, M; Wong, D; Yeh, R | 1 |
| Li, L; Ma, P; Qian, K; Zhang, M | 1 |
| Del Rosso, JQ; Kircik, LH | 1 |
| Nguyen, PL; Tung, NT; Vu, VD | 1 |
| González-Fernández, D; Pérez-Barrio, S; Rodriguez-Martín, M; Sánchez-Regaña, M; Velasco, M | 1 |
| López-Ruz, MÁ; Rosales-Castillo, A | 1 |
| Baptista, A; Coelho, H; Furtado, A; Lopes, J; Rocha, N; Sousa, C; Teixeira, D | 1 |
| de Gannes, G; Dutz, J; Han, C; Piesik, P | 1 |
| Bilge, A; Öztürk, Ö; Ulusoy, GR | 1 |
| Hu, XY; Li, JH; Li, YZ; Song, HX; Wu, T; Ye, Y | 1 |
| Yahya, H | 1 |
| García-Legaz Martínez, M; Magdaleno-Tapial, J; Martínez-Doménech, Á; Pérez-Ferriols, A; Pérez-Pastor, G; Valenzuela-Oñate, C | 1 |
| Fukaya, S; Fukuyasu, A; Hau, CS; Hayashi, K; Ishikawa, T; Kamata, M; Ohnishi, T; Shimizu, T; Tada, Y; Takeoka, S; Tanaka, T | 1 |
| Antunes, J; Balak, DMW; Becla, L; Bewley, A; Calzavara-Pinton, P; Carrascosa, JM; Gregoriou, S; Nyeland, ME; Sawyer, LM; Viola, MG | 1 |
| Gerdes, S; Hubo, M; Velasco, M; Veverka, KA; Wu, JJ | 1 |
| Abramovits, W; Hoejen, MN; Liljedahl, M; Seyger, M; Teng, J | 1 |
| Agbo-Godeau, S; Bernard, P; Boralevi, F; Francès, C; Fricain, JC; Le Gouge, A; Leducq, S; Pascal, F; Passeron, T; Samimi, M; Vaillant, L | 1 |
| Anger, T; Del Rosso, J; Hansen, B; Kircik, LH; Patel, DS; Veverka, KA | 1 |
| Barbaud, A; Bataille, P; Chasset, F; De Risi-Pugliese, T; Monfort, JB; Senet, P | 1 |
| Iyengar, S; Lee, J; Zinn, Z | 1 |
| Fibeger, E; Milosavljevic, K; Virata, AR | 1 |
| Allenby, K; Bagel, J; Sidgiddi, S; Stein Gold, L | 1 |
| Akiyama, M; Ando, Y; Ohshima, Y; Takama, H; Watanabe, D; Yanagishita, T | 1 |
| Gregoriou, S; Kostakis, P; Panagakis, P; Polydorou, D; Rigopoulos, D; Rompoti, N; Sidiropoulou, P; Tsimpidakis, A; Tsironi, T | 1 |
| Chen, H; Gu, J; Li, M; Liu, X; Lou, D; Sun, J; Sun, Q; Wen, H; Yang, H; Zhang, J | 1 |
| Alejo, B; Domínguez, M; Ertekin, SS; Herrero, A; Iglesias, P; Malvehy, J; Martinez, N; Puig, S; Villa-Crespo, L; Yélamos, O; Zamora-Barquero, S | 1 |
| Bradford, J; Chin, S; Fischer, G; Lee, G; Scurry, J | 1 |
| Abdul Hamid, M; van Delft, LCJ; van Leersum, FS | 1 |
| Gold, LS; Hansen, JB; Patel, D; Strober, B; Veverka, KA | 1 |
| Flowers, AB; Hirani, S; Kulkarni, S | 1 |
| Camela, E; Cinelli, E; Fabbrocini, G; Megna, M | 1 |
| Hagiwara, M; Katayama, H; Koda, M; Matsuo, K; Nakagawa, H; Sasaki, H; Takahashi, H; Tanito, K; Uwajima, Y | 1 |
| Braun, E; David, A; Descargues, P; Grolleau, JL; Hebsgaard, J; Jardet, C; Lovato, P; Norsgaard, H | 1 |
| Ashizawa, S; Hide, M; Takahagi, S; Tanaka, A | 1 |
| Lebwohl, M; Petersen, B | 1 |
| Alonso-Llamazares, J; Cantrell, W; Kircik, L; Koo, J; Moore, A; Stein Gold, L; Teng, J | 1 |
| de Victoria Fernández, B; González Sánchez, IC; Redondo-Sendino, Á | 1 |
| Brown, H; Jenkins, D; Lamrock, E | 1 |
| Gold, LS; Kircik, L; Lacour, JP; Lebwohl, M; Liljedahl, M; Lynde, C; Mørch, MH; Papp, KA; Perrot, JL; Takhar, A; Thaçi, D; Warren, RB; Wollenberg, A | 1 |
| Kircik, LH; Schlesinger, TE; Tanghetti, E | 1 |
| Abramovits, W; Gupta, AK; Teng, JMC; Vincent, KD | 1 |
| Hansen, JB; Nyholm, N; Patel, DS; Swensen, AR; Veverka, KA; Wu, JJ | 1 |
| Ayyagari, R; Glick, B; Guerin, A; Jacobson, A; Joseph, G; Kircik, L; Lin, T | 1 |
| Cao, S; Chen, K; Chen, Y; Cheng, H; Ding, Y; Fang, H; Han, X; He, L; He, Y; Huang, J; Li, M; Li, S; Li, W; Liu, L; Lu, Q; Lu, Y; Pan, W; Wang, J; Yan, G; Zhang, C; Zhang, J; Zheng, M; Zhu, W | 1 |
| Di Guida, A; Fabbrocini, G; Napolitano, M; Patruno, C | 1 |
| Bagel, J; Hetzel, A; Nelson, E; Riley, C | 1 |
| Chen, H; Diao, Q; Gao, Y; Geng, L; He, C; He, Y; Hu, F; Ji, C; Jin, H; Jing, H; Li, L; Li, X; Li, Y; Liu, X; Lu, Q; Lu, T; Lv, C; Miao, G; Shi, J; Shi, Y; Song, J; Wang, R; Wang, X; Wang, Y; Xia, J; Xia, X; Yan, M; Yang, X; Zhang, L; Zhang, R; Zhang, S; Zhang, X; Zheng, M; Zhou, X | 1 |
| Abd Elazim, NE; Abdel Gaber, RM; El-Deek, HEM; Fathy, E; Kamal, A | 1 |
| Agnihothri, R; Gadarowski, MB; Plovanich, M; Scott, G | 1 |
| Hegde, AR; Jagadish, PC; Jain, S; Kini, SG; Mullick, P; Mutalik, S; Mutalik, SP; Pandey, A | 1 |
| Paul, C; Romiti, R; Stein Gold, L | 1 |
| Jalili, A; Yosipovitch, G | 1 |
| Iversen, L; Koo, J; Tada, Y | 1 |
| Armstrong, A; Gerdes, S | 1 |
| Lebwohl, M; Warren, RB | 1 |
| Balogh, EA; Feldman, SR; Heron, CE; Purvis, CG | 1 |
| Alajbeg, I; Brailo, V; Rogulj, AA; Škrinjar, I; Vučićević-Boras, V; Z Alajbeg, I; Žužul, I | 1 |
| Dhawan, S; Green, LJ; Praestegaard, M; Selmer, J; Stein Gold, L; Vestbjerg, B | 1 |
| Gold, M; Gooderham, M; Kircik, LH; Lacour, JP; Laws, P; Liljedahl, M; Lynde, C; Mørch, MH; Sondermann, W; Thaçi, D; Warren, RB | 1 |
| Nyholm, N; Petersen, B; Stein Gold, L; Takhar, A; Thoning, H | 1 |
| Asahina, A; Asawanonda, P; Frez, ML; Hyun Kim, D; Imafuku, S; Theng, C; Wang, L; Zhang, JA; Zhao, Y; Zimmo, S | 1 |
| Gooderham, M; Harvima, RJ; Nyholm, N; Stein Gold, L; Thoning, H; Tyring, S | 1 |
| Bianchi, L; Caposciutti, P; Hansel, K; Marietti, R; Sensini, C; Stingeni, L; Tramontana, M | 1 |
| Argenziano, G; Atzori, L; Bianchi, L; Campanati, A; Corazza, M; Damiani, G; De Pità, O; Donini, M; Fargnoli, MC; Feliciani, C; Mazzatenta, C; Mazzotta, A; Offidani, A; Peris, K; Potenza, C; Prignano, F; Stingeni, L; Tiberio, R | 1 |
| Dongala, T; Katari, NK; Marisetti, VM; Muchakayala, SK; Pavithra, K; Vegesna, RVK | 1 |
| Hansen, JB; Kircik, L; Stein Gold, L; Veverka, KA; Yaloumis, M | 1 |
| Bouceiro-Mendes, R; Garrido, PM; Kutzner, H; Mendonça-Sanches, M; Soares-de-Almeida, L | 1 |
| Augustin, M; Gold, LS; Green, LJ; Pinter, A; Praestegaard, M; Selmer, J | 1 |
| Calzavara-Pinton, P; Dapavo, P; De Simone, C; Fabbrocini, G; Malagoli, P; Martella, A | 1 |
| Carlisle, R; Ferrel, M; Flint, ND; Hopkins, ZH; Rhoads, JLW; Secrest, AM | 1 |
| Bagel, J; Nelson, E | 1 |
| Armstrong, A; Koo, J; Pinter, A; Præstegaard, M; Reich, A; Selmer, J | 1 |
| Kircik, L; Ozyurekoglu, E | 1 |
| Amoruso, GF; Baglieri, F; Biamonte, AS; Bianchelli, T; Bigi, L; Bortoli, J; Brunetti, B; Buligan, C; Cagni, E; Calderoni, O; Calzavara-Pinton, P; Campanati, A; Campione, E; Caputo, A; Carrera, CG; Carugno, A; Chersi, K; Cicchelli, S; Dapavo, P; De Natale, F; De Simone, C; Di Maria, D; Errichetti, E; Fabbrocini, G; Ferrari, AS; Fogli, E; Forconi, R; Franchi, C; Galeazzi, A; Gambardella, A; Giovannini, A; Giura, MT; Iuculano, M; Lazzaretti, G; Leporati, C; Magnanini, M; Malagoli, P; Marconi, B; Martella, A; Maruccia, A; Megna, M; Miglietta, R; Minuti, A; Mocci, L; Modica, S; Narcisi, A; Odorici, G; Osti, F; Pazzaglia, M; Peila, R; Pertusi, G; Pezza, M; Pezzullo, E; Puccia, N; Raulo, U; Ribero, S; Rossi, M; Rusignuolo, S; Sapienza, G; Savarese, C; Scalisi, M; Strippoli, D; Stroppiana, E; Tiberio, R; Trischitta, A; Tucci, MG; Vaira, F; Verrone, A; Villa, L; Zagni, F; Zagni, G; Zoccali, A | 1 |
| Feldman, SR; Singh, R; Taylor, A | 1 |
| Beebeejaun, MT; Brown, MB; Hutter, V; Kravitz, L; McAuley, WJ | 1 |
| Mehta, TA; Patel, V | 1 |
| Abdullah, M; Ahmad, A; Ahmed, M; Anjum, S; Nadeem, R; Rashid, S; Shah, SAA; Ul-Haq, Z; Zia, K | 1 |
| Czerwińska, J; Kasprowicz-Furmańczyk, M; Owczarczyk-Saczonek, A; Placek, W | 1 |
| Avey, B; Baker, H; Barker, E; Bewley, A; Galván, J; Green, W; Pi-Blanque, A; Praestegaard, M; Trebbien, P | 1 |
| Bourlioux, M; Fuchs, CSK; Haedersdal, M; Mandel, VD; Nissen, CV; Ortner, VK; Philipsen, PA; Skak, K; Zibert, JR | 1 |
| Collier, MR; Devjani, S; Egeberg, A; Oulee, A; Smith, B; Wu, JJ | 1 |
| Armstrong, AW; Augustin, M; Danø, A; Dhawan, S; Galván, J; Gold, LS; Green, LJ; Pinter, A; Praestegaard, M; Reich, A; Selmer, J; Stallknecht, SE; Trebbien, P | 1 |
| Alexis, A; Cices, A; Kaufman, B; Liu, J; Sanabria-Gonzalez, I | 1 |
| Hou, YL; Lin, SH | 1 |
| Bhatia, N; Callender, VD; Curcio, A; Feldman, SR; Gorodokin, B; Kircik, L; Kontzias, CL; Tissera, KA | 1 |
| Arenberger, P; Armstrong, A; Augustin, M; Gold, LS; Iversen, L; Pinter, A; Praestegaard, M; Reich, A | 1 |
| Armstrong, AW; Kircik, L; Lee, K | 1 |
40 review(s) available for betamethasone and betamethasone-17,21-dipropionate
| Article | Year |
|---|---|
Some methods for evaluating clinical itch and their application for studying pathophysiological mechanisms.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Cytokines; Dermatitis, Atopic; Glucocorticoids; Histamine; Humans; Pain Measurement; Pruritus; Sensation | 1992 |
Topical clobetasol-17-propionate: review of its clinical efficacy and safety.
Topics: Administration, Topical; Betamethasone; Clobetasol; Combined Modality Therapy; Drug Administration Schedule; Eczema; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Psoriasis | 1986 |
Lichen sclerosus in childhood.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Child; Child Abuse, Sexual; Child, Preschool; Female; Glucocorticoids; Humans; Lichen Sclerosus et Atrophicus; Male; Prognosis; Vulvar Diseases | 1995 |
Linear scleroderma in children.
Topics: Administration, Topical; Adolescent; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Betamethasone; Child; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Penicillins; Phenytoin; Scleroderma, Localized; Ticlopidine; Vitamin E | 1996 |
Herpes zoster-associated trigeminal neurotrophic ulcer.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Female; Glucocorticoids; Herpes Zoster Ophthalmicus; Humans; Scalp; Skin Ulcer; Trigeminal Nerve; Trigeminal Neuralgia | 1996 |
Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations.
Topics: Administration, Topical; Adrenal Glands; Adult; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Clobetasol; Depression, Chemical; Female; Glucocorticoids; Humans; Male; Ointments; Psoriasis; Self Medication | 1998 |
Chronic ulcerative stomatitis: a case report.
Topics: Administration, Topical; Anti-Inflammatory Agents; Antibodies, Antinuclear; Betamethasone; Chronic Disease; Epithelium; Female; Fluorescent Antibody Technique, Direct; Gingivitis; Gingivitis, Necrotizing Ulcerative; Glucocorticoids; Humans; Immunoglobulin G; Middle Aged; Xerostomia | 2000 |
Fixed-dose combination therapy for psoriasis.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Dermatologic Agents; Drug Therapy, Combination; Humans; Psoriasis; Randomized Controlled Trials as Topic; Severity of Illness Index | 2004 |
Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Humans; Psoriasis; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
Ultrapotent topical corticosteroid treatment of hemangiomas of infancy.
Topics: Administration, Cutaneous; Betamethasone; Clobetasol; Extremities; Eye Neoplasms; Eyelids; Facial Neoplasms; Female; Hemangioma; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2005 |
A two-compound product containing calcipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severity.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Calcitriol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Randomized Controlled Trials as Topic; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
[The calcipotriol-betamethasone dipropionate association].
Topics: Administration, Topical; Betamethasone; Calcitriol; Drug Therapy, Combination; Humans; Inflammation; Psoriasis | 2005 |
Calcipotriol/betamethasone dipropionate for the treatment of psoriasis.
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Cell Differentiation; Cell Proliferation; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Drug Synergism; Humans; Keratinocytes; Psoriasis; Randomized Controlled Trials as Topic; Treatment Outcome | 2006 |
[How I treat...topical treatment of plaque type psoriasis by the combination of calcipotriol and betamethasone dipropionate].
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; Psoriasis | 2006 |
[Calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis. A review].
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Gels; Humans; Incidence; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2010 |
Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris.
Topics: Administration, Topical; Adult; Algorithms; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Treatment Outcome | 2011 |
Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Cost-Benefit Analysis; Drug Combinations; Gels; Humans; Models, Econometric; Psoriasis; Scalp Dermatoses; Scotland; Severity of Illness Index; Treatment Outcome | 2011 |
The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderately severe scalp psoriasis: a systematic review of direct and indirect evidence.
Topics: Administration, Topical; Algorithms; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Drug Combinations; Evidence-Based Practice; Gels; Humans; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2011 |
Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
Topics: Back; Betamethasone; Calcitriol; Clinical Trials as Topic; Dermatologic Agents; Drug Combinations; Extremities; Gels; Humans; Ointments; Psoriasis; Scalp; Thorax; Treatment Outcome | 2011 |
In touch with psoriasis: topical treatments and current guidelines.
Topics: Administration, Topical; Betamethasone; Calcitriol; Dermatologic Agents; Humans; Practice Guidelines as Topic; Psoriasis | 2011 |
Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
Topics: Administration, Cutaneous; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Extremities; Gels; Humans; Ointments; Psoriasis; Scalp; Torso | 2011 |
Solitary morphea profunda following trauma sustained in an automobile accident.
Topics: Accidents, Traffic; Anti-Inflammatory Agents; Antirheumatic Agents; Arm Injuries; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Middle Aged; Prednisone; Scleroderma, Localized | 2015 |
Topical Therapies for Psoriasis: Improving Management Strategies and Patient Adherence.
Topics: Administration, Cutaneous; Anthralin; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Nicotinic Acids; Patient Compliance; Pharmaceutical Vehicles; Practice Guidelines as Topic; Psoriasis; Quality of Life; Severity of Illness Index; Tacrolimus; Treatment Outcome; Vitamin D | 2016 |
Clear Cell Acanthoma of the Areola and Nipple.
Topics: Acanthoma; Aged; Betamethasone; Breast Neoplasms; Female; Gentamicins; Humans; Nipples; Skin Neoplasms | 2016 |
Impact of Measuring Patient-Reported Outcomes in Dermatology Drug Development.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Female; Humans; Male; Middle Aged; Patient Reported Outcome Measures; Patient Satisfaction; Quality of Life; Self Report; Skin Diseases; Surveys and Questionnaires | 2017 |
Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Psoriasis; Quality of Life | 2016 |
DFD-01: a novel topical formulation of betamethasone dipropionate for the treatment of extensive psoriasis.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Clinical Trials, Phase III as Topic; Humans; Patient Compliance; Psoriasis; Skin Cream; Treatment Outcome | 2017 |
Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Quality of Life | 2017 |
Update on Topical Treatments for Psoriasis: The Role of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam.
Topics: Administration, Topical; Aerosols; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Humans; Psoriasis | 2019 |
Erosive pustular dermatosis of the scalp - an Australian perspective: Insights to aid clinical practice.
Topics: Algorithms; Anti-Inflammatory Agents; Australia; Betamethasone; Calcineurin Inhibitors; Curettage; Dermoscopy; Diagnosis, Differential; Glucocorticoids; Humans; Incidence; Mometasone Furoate; Recurrence; Scalp Dermatoses; Skin Diseases, Vesiculobullous; Tacrolimus | 2019 |
Necrobiosis lipoidica in a Nigerian woman - Report of a case.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Female; Humans; Leg; Middle Aged; Necrobiosis Lipoidica; Nigeria; Rare Diseases; Treatment Outcome | 2019 |
Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: a review of real-world evidence (RWE).
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2021 |
Betamethasone dipropionate spray 0.05% alleviates troublesome symptoms of plaque psoriasis.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Betamethasone; Humans; Psoriasis; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis | 2020 |
Fixed Combination Calcipotriene and Betamethasone Dipropionate (Cal/BD) Foam for Beyond-Mild Psoriasis: A Possible Alternative to Systemic Medication.
Topics: Administration, Cutaneous; Aerosols; Betamethasone; Biological Products; Calcitriol; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Humans; Psoriasis; Randomized Controlled Trials as Topic; Severity of Illness Index; Thalidomide; Treatment Outcome | 2020 |
Systematic review and practical guidance on the use of topical calcipotriol and topical calcipotriol with betamethasone dipropionate as long-term therapy for mild-to-moderate plaque psoriasis.
Topics: Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2021 |
A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis.
Topics: Betamethasone; Calcitriol; Clinical Trials, Phase III as Topic; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice.
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2022 |
Review of Calcipotriene and Betamethasone Dipropionate Cream in the Treatment of Psoriasis.
Topics: Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2023 |
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30
Topics: Adult; Betamethasone; Clinical Trials, Phase III as Topic; Dermatologic Agents; Drug Combinations; Emollients; Humans; Psoriasis; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome; Venereology | 2023 |
171 trial(s) available for betamethasone and betamethasone-17,21-dipropionate
| Article | Year |
|---|---|
Local treatment of psoriasis with desoxymethasone and betamethasone 17,21-dipropionate: a double-blind comparison.
Topics: Administration, Topical; Adolescent; Betamethasone; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; Female; Humans; Male; Psoriasis | 1977 |
The comparative efficacy of betamethasone dipropionate cream and ointment formulations in the treatment of psoriasis.
Topics: Betamethasone; Chronic Disease; Female; Humans; Male; Middle Aged; Ointments; Psoriasis | 1979 |
Comparison of synemol cream and other topical corticosteroid creams using the vasoconstrictor bioassay.
Topics: Administration, Topical; Betamethasone; Betamethasone Valerate; Blood Vessels; Cresols; Drug Combinations; Fluocinolone Acetonide; Humans; Time Factors; Triamcinolone | 1977 |
Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrhoeic dermatitis in adults.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Seborrheic; Female; Gels; Glucocorticoids; Humans; Ketoconazole; Male; Middle Aged; Ointments; Single-Blind Method | 1992 |
Synergistic effects of oral nonsteroidal drugs and topical corticosteroids in the therapy of sunburn in humans.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Biopsy; Blood Flow Velocity; Drug Synergism; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Ibuprofen; Indomethacin; Lasers; Male; Middle Aged; Random Allocation; Skin; Sunburn | 1992 |
[Evaluation of the effect of local corticosteroids in the phototherapy of psoriasis].
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Combined Modality Therapy; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Ultraviolet Therapy | 1991 |
Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis.
Topics: Administration, Topical; Adult; Allylamine; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Clotrimazole; Double-Blind Method; Drug Combinations; Female; Glucocorticoids; Humans; Male; Ointments; Tinea Pedis | 1992 |
A double-blind, multicenter comparison between 0.05% halobetasol propionate ointment and 0.05% betamethasone dipropionate ointment in chronic plaque psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Clobetasol; Double-Blind Method; Female; Germany; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Patient Satisfaction; Psoriasis; Remission Induction; Vasoconstrictor Agents; Wound Healing | 1991 |
Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitis.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Clobetasol; Dermatitis, Atopic; Double-Blind Method; Female; Germany, West; Glucocorticoids; Humans; Male; Middle Aged; Patient Satisfaction; Remission Induction; Vasoconstrictor Agents | 1991 |
Safety and efficacy of mometasone furoate cream in the treatment of steroid responsive dermatoses.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Atrophy; Betamethasone; Female; Humans; Hydrocortisone; Male; Middle Aged; Mometasone Furoate; Pregnadienediols; Single-Blind Method; Skin Diseases | 1991 |
Intermittent corticosteroid maintenance treatment of psoriasis: a double-blind multicenter trial of augmented betamethasone dipropionate ointment in a pulse dose treatment regimen.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydrocortisone; Male; Middle Aged; Ointments; Psoriasis; Time Factors | 1991 |
A double-blind controlled comparison of generic and trade-name topical steroids using the vasoconstriction assay.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Fluocinolone Acetonide; Glucocorticoids; Humans; Middle Aged; Therapeutic Equivalency; Vasoconstriction | 1991 |
Topical retinoic acid does not alter the vasoconstrictive properties of topical corticosteroids in humans.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Clobetasol; Female; Glucocorticoids; Humans; Male; Skin; Tretinoin; Triamcinolone Acetonide; Vasoconstriction | 1991 |
Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris.
Topics: Adult; Betamethasone; Dermatitis, Atopic; Double-Blind Method; Drug Carriers; Female; Humans; Liposomes; Male; Psoriasis | 1990 |
[The effect of initial external glucocorticoid administration on cignolin treatment of psoriasis].
Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Betamethasone; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Humans; Psoriasis; Randomized Controlled Trials as Topic | 1990 |
The role of fish oil in psoriasis. A randomized, double-blind, placebo-controlled study to evaluate the effect of fish oil and topical corticosteroid therapy in psoriasis.
Topics: Adult; Betamethasone; Body Surface Area; Double-Blind Method; Female; Fish Oils; Humans; Male; Middle Aged; Plant Oils; Psoriasis | 1990 |
[Intra-articular treatment of osteoarthrosis of the knee with betamethasone dipropionate and disodium phosphate. Non-controlled, open 5 years' experience].
Topics: Adult; Aged; Betamethasone; Female; Humans; Injections, Intra-Articular; Knee Joint; Male; Middle Aged; Osteoarthritis | 1989 |
0.05 percent betamethasone dipropionate in optimized cream vehicle for psoriasis.
Topics: Adolescent; Adult; Betamethasone; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Ointment Bases; Psoriasis | 1989 |
Preatrophy: covert sign of thinned skin.
Topics: Adult; Aged; Atrophy; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Female; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Random Allocation; Skin | 1989 |
Surgical versus medical treatment of nasal polyps.
Topics: Administration, Intranasal; Airway Resistance; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intramuscular; Nasal Polyps; Neoplasm Recurrence, Local; Prospective Studies; Random Allocation | 1989 |
A double-blind comparison of the efficacy of betamethasone dipropionate cream twice daily versus once daily in the treatment of steroid responsive dermatoses.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Double-Blind Method; Eczema; Glucocorticoids; Humans; Middle Aged; Psoriasis | 1989 |
[Treatment with topical corticosteroids in severe or resistant dermatoses].
Topics: Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Dermatitis, Atopic; Dermatitis, Seborrheic; Desoximetasone; Dexamethasone; Double-Blind Method; Drug Tolerance; Female; Humans; Hydrocortisone; Male; Middle Aged; Ointments; Psoriasis; Safety; Skin Diseases; Time Factors | 1985 |
Betamethasone dipropionate (0.05)% plus chinoform (3%) cream against betamethasone valerate (0.1%) plus chinoform cream (3%) in secondarily infected dermatoses.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Child; Child, Preschool; Clioquinol; Drug Combinations; Female; Glucocorticoids; Humans; Hydroxyquinolines; Male; Middle Aged; Ointments; Random Allocation; Skin Diseases | 1987 |
Psoriasis of the scalp treated with Grenz rays or topical corticosteroid combined with Grenz rays. A comparative randomized trial.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Combined Modality Therapy; Glucocorticoids; Humans; Middle Aged; Psoriasis; Random Allocation; Scalp Dermatoses | 1988 |
Intramuscular betamethasone dipropionate vs. topical beclomethasone dipropionate and placebo in hay fever.
Topics: Administration, Intranasal; Adolescent; Adult; Betamethasone; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Pollen; Random Allocation; Rhinitis, Allergic, Seasonal | 1988 |
Additional effect of grenz rays on psoriasis lesions of the scalp treated with topical corticosteroids.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Humans; Middle Aged; Psoriasis; Scalp Dermatoses | 1987 |
A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Drug Tolerance; Follow-Up Studies; Glucocorticoids; Humans; Ointments; Psoriasis; Time Factors | 1986 |
Superpotent topical steroid treatment of psoriasis vulgaris--clinical efficacy and adrenal function.
Topics: Administration, Topical; Adolescent; Adrenal Glands; Adult; Aged; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Female; Humans; Hydrocortisone; Male; Middle Aged; Psoriasis; Random Allocation | 1987 |
Betamethasone dipropionate in optimized vehicle. Intermittent pulse dosing for extended maintenance treatment of psoriasis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Drug Administration Schedule; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Random Allocation | 1987 |
Betamethasone dipropionate cream for the treatment of psoriasis. A double-blind comparison with clobetasol propionate cream.
Topics: Betamethasone; Clobetasol; Double-Blind Method; Humans; Psoriasis | 1985 |
Treatment of urticaria pigmentosa with corticosteroids.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Atrophy; Betamethasone; Biopsy; Child, Preschool; Female; Histamine; Humans; Injections, Intradermal; Male; Mast Cells; Middle Aged; Occlusive Dressings; Skin; Time Factors; Triamcinolone Acetonide; Urticaria Pigmentosa | 1985 |
Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Budesonide; Glucocorticoids; Humans; Hydrocortisone; Male; Occlusive Dressings; Ointments; Pregnenediones | 1981 |
Systemic side-effects of three topical steroids in diseased skin.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Budesonide; Clinical Trials as Topic; Dermatitis, Exfoliative; Female; Glucocorticoids; Humans; Male; Middle Aged; Pregnenediones; Psoriasis | 1983 |
[Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution].
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Dermatitis; Dermatitis, Seborrheic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Eczema; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Salicylates; Salicylic Acid | 1983 |
A comparative multicentre trial of halometasone/triclosan cream and betamethasone dipropionate/gentamicin sulphate cream in the treatment of infected acute eczematous dermatitis.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Drug Combinations; Eczema; Female; Gentamicins; Humans; Male; Middle Aged; Phenyl Ethers; Triclosan | 1983 |
[Comparative clinical trial of a new trihalogenated dermatocorticoid (halometasone) versus betamethasone dipropionate].
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Drug Tolerance; Eczema; Female; Glucocorticoids; Humans; Male; Middle Aged | 1983 |
[Diflorasone diacetate cream compared to betamethasone dipropionate cream in the treatment of eczemas].
Topics: Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Eczema; Female; Humans; Male; Middle Aged; Ointments; Random Allocation; Time Factors | 1983 |
Diprosone (betamethasone dipropionate) cream 0.05%. A review and interim report of a comparative multi-centre study versus betamethasone valerate 0.1%.
Topics: Betamethasone; Betamethasone Valerate; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Skin Diseases; Time Factors | 1983 |
Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Drug Administration Schedule; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis | 1983 |
A double-blind controlled evaluation of Diproderm cream 0.05%, twice a day treatment in comparison with once a day treatment in eczema.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Eczema; Female; Glucocorticoids; Humans; Male; Ointments | 1984 |
Studies on the efficacy and adrenal effects of Diprolene ointment 0.05 percent and Dermovate ointment 0.05 percent in patients with psoriasis or other resistant dermatoses.
Topics: Adult; Aged; Betamethasone; Clinical Trials as Topic; Clobetasol; Double-Blind Method; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Ointments; Pituitary-Adrenal System; Psoriasis; Random Allocation | 1984 |
[Results of a multicenter double-blind study in patients with resistant psoriasis and atopic dermatitis. Diprolene ointment vs. Dermovate ointment].
Topics: Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Clobetasol; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Male; Middle Aged; Ointments; Psoriasis | 1984 |
SCH 370 (clotrimazole-betamethasone dipropionate) cream in patients with tinea cruris or tinea corporis.
Topics: Adult; Betamethasone; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Ointments; Random Allocation; Tinea | 1984 |
Vasoconstrictor and the anti-inflammatory effects of 7 corticosteroids.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Betamethasone; Betamethasone Valerate; Clobetasol; Dermatitis, Contact; Female; Humans; Hydrocortisone; Male; Middle Aged; Patch Tests; Skin; Triamcinolone Acetonide; Vasoconstriction | 1984 |
Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Child; Child, Preschool; Clobetasol; Dermatitis, Atopic; Desonide; Diflucortolone; Drug Administration Schedule; Female; Fluocortolone; Halcinonide; Humans; Hydrocortisone; Infant; Male; Ointments | 1984 |
A double-blind trial of budesonide and betamethasone- 17,21-dipropionate in psoriasis.
Topics: Adolescent; Adult; Aged; Betamethasone; Budesonide; Child; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Occlusive Dressings; Pregnenediones; Psoriasis | 1982 |
A double-blind study comparing the superiority of a combination antifungal (clotrimazole)/steroidal (betamethasone dipropionate) product.
Topics: Betamethasone; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Drug Combinations; Female; Humans; Imidazoles; Male; Random Allocation; Tinea | 1982 |
Effect of salicylic acid on the activity of betamethasone-17,21-dipropionate in the treatment of erythematous squamous dermatoses.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Drug Combinations; Drug Evaluation; Drug Interactions; Drug Synergism; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Salicylates; Salicylic Acid; Scalp Dermatoses | 1983 |
Once-daily treatment of psoriasis with topical glucocorticosteroid ointments.
Topics: Administration, Topical; Adult; Betamethasone; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Ointments; Psoriasis | 1983 |
Efficacy of a betamethasone dipropionate topical glycol preparation in the management of severe psoriasis.
Topics: Administration, Topical; Betamethasone; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Propylene Glycols; Psoriasis | 1980 |
[Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Betamethasone; Child; Clinical Trials as Topic; Clobetasol; Desoximetasone; Diflucortolone; Double-Blind Method; Eczema; Humans; Middle Aged; Neurodermatitis; Psoriasis | 1981 |
Treatment of psoriasis of the scalp with betamethasone 17, 21-dipropionate plus salicylic acid lotion ('Diprosalic').
Topics: Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Salicylates; Salicylic Acid; Scalp Dermatoses; Time Factors | 1981 |
Comparison of diflorasone diacetate and betamethasone dipropionate ointment in the treatment of psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Cresols; Drug Combinations; Erythema; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Psoriasis; Time Factors | 1982 |
Comparison of betamethasone dipropionate lotion with salicylic acid (Diprosalic) and clobetasol propionate lotion (Dermovate) in the treatment of psoriasis of the scalp.
Topics: Anti-Inflammatory Agents; Betamethasone; Clobetasol; Drug Evaluation; Female; Humans; Hydrocortisone; Male; Psoriasis; Salicylates; Scalp Dermatoses; Suspensions | 1982 |
Calcipotriol: clinical trial versus betamethasone dipropionate + salicylic acid.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Glucocorticoids; Humans; Psoriasis; Salicylates; Salicylic Acid | 1994 |
Betamethasone dipropionate polyacrylic film-forming lotion in the treatment of hand dermatitis.
Topics: Acrylic Resins; Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Eczema; Emollients; Erythema; Female; Glucocorticoids; Hand Dermatoses; Humans; Male; Middle Aged; Pharmaceutical Vehicles; Pruritus | 1993 |
Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids.
Topics: Betamethasone; Clobetasol; Double-Blind Method; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Psoriasis | 1993 |
Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Esthetics; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Patient Satisfaction; Psoriasis | 1993 |
Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Female; Fluticasone; Humans; Hydrocortisone; Male; Middle Aged; Ointments; Psoriasis | 1996 |
A comparison of the safety, tolerability, and efficacy of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of eczema.
Topics: Administration, Topical; Adolescent; Adult; Aged; Androstadienes; Anti-Inflammatory Agents; Betamethasone; Child; Double-Blind Method; Drug Tolerance; Eczema; Female; Fluticasone; Humans; Hydrocortisone; Male; Middle Aged; Ointments; Safety | 1996 |
Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Atrophy; Betamethasone; Blotting, Western; Double-Blind Method; Drug Therapy, Combination; Epidermis; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Tretinoin | 1996 |
Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Creatinine; Cyclosporine; Double-Blind Method; Drug Tolerance; Eczema; Female; Glucocorticoids; Hand Dermatoses; Humans; Immunosuppressive Agents; Male; Middle Aged; Ointments; Recurrence; Treatment Outcome | 1996 |
Augmented betamethasone: efficacy in psoriasis with different dosing frequencies.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Betamethasone; Confidence Intervals; Double-Blind Method; Drug Administration Schedule; Female; Glucocorticoids; Humans; Male; Ointments; Pharmaceutical Vehicles; Psoriasis; Remission Induction | 1996 |
Comparison of the influence of cyclosporine and topical betamethasone-17,21-dipropionate treatment on quality of life in chronic hand eczema.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Chronic Disease; Cyclosporine; Eczema; Female; Glucocorticoids; Hand Dermatoses; Humans; Male; Middle Aged; Quality of Life | 1997 |
The effect of topically applied corticosteroid on irritant and allergic patch test reactions.
Topics: Administration, Topical; Allergens; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Allergic Contact; Dermatitis, Irritant; Double-Blind Method; Drug Eruptions; Follow-Up Studies; Glucocorticoids; Humans; Irritants; Ointments; Patch Tests; Sodium Dodecyl Sulfate; Surface-Active Agents | 1996 |
Ultrapotent topical corticosteroid treatment of childhood genital lichen sclerosus.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Child; Child, Preschool; Clobetasol; Female; Follow-Up Studies; Genital Diseases, Female; Glucocorticoids; Humans; Lichen Sclerosus et Atrophicus | 1999 |
[Triderm in the treatment of atopic dermatitis].
Topics: Administration, Topical; Adult; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Betamethasone; Biopsy; Clotrimazole; Dermatitis, Atopic; Dermatologic Agents; Drug Combinations; Gentamicins; Glucocorticoids; Humans; Ointments; Skin | 1999 |
Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Glucocorticoids; Humans; Prospective Studies; Psoriasis; Surveys and Questionnaires; Tachyphylaxis | 1999 |
The value of colloid dressings in psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Child; Colloids; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Occlusive Dressings; Psoriasis; Treatment Outcome | 1999 |
Topical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeks.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Single-Blind Method; Treatment Outcome | 2000 |
Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: a flow cytometric study.
Topics: Adult; Aged; Betamethasone; Calcitriol; Cell Cycle; Cell Division; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Flow Cytometry; Humans; Keratin-10; Keratins; Male; Middle Aged; Psoriasis; Skin; Vimentin | 2001 |
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Psoriasis | 2002 |
A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ointments; Patient Satisfaction; Psoriasis; Reference Values; Severity of Illness Index; Sweden; Treatment Outcome | 2002 |
Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis.
Topics: Adolescent; Betamethasone; Calcitriol; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Pharmaceutical Vehicles; Prospective Studies; Psoriasis; Treatment Outcome | 2003 |
Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Europe; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Severity of Illness Index; Treatment Outcome | 2003 |
Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial.
Topics: Administration, Topical; Adult; Alopecia Areata; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Dosage Forms; Female; Humans; Male; Middle Aged; Prospective Studies; Single-Blind Method; Treatment Outcome | 2003 |
The atrophogenic potential and dermal tolerance of calcipotriol/betamethasone dipropionate ointment compared with betamethasone dipropionate ointment.
Topics: Adult; Atrophy; Betamethasone; Biopsy, Needle; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Skin; Ultrasonography | 2003 |
Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Canada; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Europe; Female; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Severity of Illness Index | 2004 |
The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
Topics: Activities of Daily Living; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Disability Evaluation; Double-Blind Method; Drug Combinations; Female; Health Status Indicators; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Quality of Life; Treatment Outcome | 2004 |
Intermittent topical corticosteroid/tacrolimus sequential therapy improves lichenification and chronic papules more efficiently than intermittent topical corticosteroid/emollient sequential therapy in patients with atopic dermatitis.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Betamethasone; Chi-Square Distribution; Chronic Disease; Dermatitis, Atopic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Emollients; Female; Follow-Up Studies; Humans; Male; Middle Aged; Probability; Risk Assessment; Tacrolimus; Treatment Outcome | 2004 |
Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial.
Topics: Administration, Topical; Adolescent; Adult; Betamethasone; Calcitriol; Confidence Intervals; Dihydroxycholecalciferols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Odds Ratio; Prospective Studies; Psoriasis; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2004 |
Lumbar zygapophyseal joint injections in patients with chronic lower back pain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthrography; Betamethasone; Chronic Disease; Drug Combinations; Female; Fluoroscopy; Humans; Injections; Iopamidol; Lidocaine; Low Back Pain; Lumbar Vertebrae; Male; Middle Aged; Treatment Outcome; Zygapophyseal Joint | 2005 |
A group III steroid solution without antibiotic components: an effective cure for external otitis.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Betamethasone; Drug Combinations; Ear Canal; Female; Humans; Hydrocortisone; Male; Middle Aged; Otitis Externa; Oxytetracycline; Polymyxin B; Treatment Outcome | 2005 |
Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Calcitriol; Confidence Intervals; Cost-Benefit Analysis; Dihydroxycholecalciferols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Costs; Europe; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ointments; Probability; Psoriasis; Reference Values; Risk Factors; Severity of Illness Index; Treatment Outcome | 2005 |
Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
Topics: Administration, Cutaneous; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Ointments; Severity of Illness Index; Treatment Outcome; Vitiligo | 2006 |
Dovobet ointment under occlusion overnight for troublesome scalp psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2006 |
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
Topics: Adult; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Eruptions; Female; Humans; Male; Middle Aged; Psoriasis; Severity of Illness Index | 2006 |
Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chi-Square Distribution; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Treatment Outcome | 2006 |
Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment.
Topics: Alefacept; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Etanercept; Female; Humans; Immunoglobulin G; Male; Middle Aged; Ointments; Psoriasis; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Retrospective Studies; Severity of Illness Index | 2006 |
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Satisfaction; Psoriasis; Safety; Time Factors; Treatment Outcome | 2006 |
Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
Topics: Administration, Topical; Adult; Alefacept; Anti-Inflammatory Agents; Antigens, CD; Betamethasone; Cell Differentiation; Cell Proliferation; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Epidermis; Humans; Immunohistochemistry; Injections, Intramuscular; Keratinocytes; Psoriasis; Recombinant Fusion Proteins; Severity of Illness Index; T-Lymphocyte Subsets; Treatment Outcome | 2007 |
Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Compliance; Patient Dropouts; Pilot Projects; Pruritus; Psoriasis; Severity of Illness Index; Time Factors; Treatment Outcome | 2006 |
Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Logistic Models; Male; Maximum Tolerated Dose; Middle Aged; Patient Satisfaction; Probability; Prospective Studies; Psoriasis; Reference Values; Risk Assessment; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2008 |
Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Nail Diseases; Psoriasis; Severity of Illness Index; Single-Blind Method | 2008 |
A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Pharmaceutical Vehicles; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Skin; Treatment Outcome | 2008 |
A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Canada; Denmark; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; France; Germany; Humans; Male; Middle Aged; Ointments; Pharmaceutical Vehicles; Prospective Studies; Psoriasis; Scalp; Severity of Illness Index; Treatment Outcome; United Kingdom | 2008 |
Comparison of ultrasound-, palpation-, and scintigraphy-guided steroid injections in the treatment of plantar fasciitis.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Body Mass Index; Fascia; Fasciitis, Plantar; Female; Foot; Humans; Injections, Intralesional; Male; Middle Aged; Pain Measurement; Palpation; Radionuclide Imaging; Ultrasonography | 2009 |
A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Drug Administration Schedule; Drug Combinations; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Treatment Outcome; Young Adult | 2009 |
Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Clobetasol; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Patient Satisfaction; Psoriasis; Quality of Life | 2009 |
Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Nail Diseases; Ointments; Psoriasis | 2009 |
Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Young Adult | 2009 |
Microcirculatory modifications of psoriatic lesions during topical therapy.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Calcitriol; Capillaries; Dermatologic Agents; Dermoscopy; Drug Therapy, Combination; Female; Humans; Male; Microcirculation; Microscopic Angioscopy; Middle Aged; Psoriasis; Skin; Treatment Outcome; Young Adult | 2009 |
Significant one week efficacy of a calcipotriol plus betamethasone dipropionate scalp formulation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psoriasis; Scalp; Young Adult | 2011 |
A calcipotriene/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8-week, double-blind phase of a clinical trial.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Black or African American; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Hispanic or Latino; Humans; Middle Aged; Psoriasis; Scalp Dermatoses; Treatment Outcome; Young Adult | 2010 |
Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE.
Topics: Adalimumab; Administration, Topical; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betamethasone; Calcitriol; Double-Blind Method; Female; Humans; Male; Middle Aged; Psoriasis; Tumor Necrosis Factor-alpha | 2011 |
Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Cyclosporine; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ointments; Pilot Projects; Psoriasis; Severity of Illness Index; Young Adult | 2012 |
The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g.
Topics: Administration, Cutaneous; Adult; Aged; Betamethasone; Budesonide; Calcitriol; Dermatologic Agents; Dihydroxycholecalciferols; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ointments; Pruritus; Psoriasis; Time Factors; Young Adult | 2011 |
Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Calcitriol; Contraceptives, Oral, Combined; Dermatologic Agents; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Male; Middle Aged; Pilot Projects; Psoriasis; Receptors, Tumor Necrosis Factor; Sample Size; Treatment Outcome | 2011 |
Pharmacokinetics of betamethasone and betamethasone 17-monopropionate in Chinese healthy volunteers after intramuscular injection of betamethasone phosphate/betamethasone dipropionate.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Chromatography, High Pressure Liquid; Electrocardiography; Half-Life; Humans; Injections, Intramuscular; Male; Mass Spectrometry; Young Adult | 2011 |
Evaluating the efficacy and safety of calcipotriene/betamethasone ointment occluded with a hydrogel patch: a 6-week bilaterally controlled, investigator-blinded trial.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Female; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Male; Middle Aged; Occlusive Dressings; Ointments; Psoriasis; Single-Blind Method; Treatment Outcome | 2011 |
Local steroid therapy as the first-line treatment for boys with symptomatic phimosis - a long-term prospective study.
Topics: Administration, Cutaneous; Adolescent; Betamethasone; Child; Child, Preschool; Follow-Up Studies; Glucocorticoids; Humans; Infant; Male; Phimosis; Prospective Studies; Treatment Outcome | 2012 |
Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Janus Kinase 1; Janus Kinase 2; Male; Middle Aged; Nitriles; Pilot Projects; Psoriasis; Pyrazoles; Pyrimidines; Signal Transduction; Treatment Outcome; Young Adult | 2012 |
Blind or ultrasound-guided corticosteroid injections and short-term response in subacromial impingement syndrome: a randomized, double-blind, prospective study.
Topics: Activities of Daily Living; Anesthetics, Local; Anti-Inflammatory Agents; Betamethasone; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Humans; Injections, Intra-Articular; Magnetic Resonance Imaging; Male; Middle Aged; Pain Measurement; Prilocaine; Prospective Studies; Range of Motion, Articular; Recovery of Function; Shoulder Impingement Syndrome; Shoulder Joint; Shoulder Pain; Ultrasonography, Interventional | 2012 |
Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Endpoint Determination; Female; Humans; Immunoglobulin A; Male; Middle Aged; Pharmaceutical Vehicles; Psoriasis; Quality of Life; Skin; Suspensions | 2013 |
Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patients.
Topics: Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Psoriasis; Recurrence; Scalp Dermatoses; Young Adult | 2014 |
Efficacy and safety of calcipotriol/betamethasone dipropionate ointment for the treatment of simple onycholysis: an open-label study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Child; Child, Preschool; Dermatologic Agents; Drug Combinations; Female; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Ointments; Onycholysis; Severity of Illness Index; Young Adult | 2013 |
Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial.
Topics: Administration, Cutaneous; Adult; Betamethasone; Calcitriol; Calcium; Creatinine; Dermatologic Agents; Drug Combinations; Female; Follow-Up Studies; Gels; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Pituitary-Adrenal System; Psoriasis; Severity of Illness Index; Suspensions; Time Factors | 2013 |
Betamethasone valerate dressing is non-inferior to calcipotriol-betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial.
Topics: Anti-Inflammatory Agents; Bandages; Betamethasone; Betamethasone Valerate; Calcitriol; Chronic Disease; Dermatologic Agents; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Single-Blind Method | 2014 |
Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of age.
Topics: Administration, Cutaneous; Adolescent; Betamethasone; Calcitriol; Child; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2014 |
Alternative treatment with calcipotriol plus betamethasone dipropionate gel in psoriasis vulgaris using a short-contact approach.
Topics: Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Female; Gels; Humans; Male; Middle Aged; Psoriasis; Treatment Outcome; Young Adult | 2014 |
A randomized, double-blinded trial evaluating the efficacy and tolerability of vectical ointment (calcitriol 3 mcg/g ointment) when compared to betamethasone diproprionate ointment (64 mg/g) in patients with nail psoriasis.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Double-Blind Method; Female; Humans; Male; Nail Diseases; Ointments; Psoriasis; Treatment Outcome | 2014 |
Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study.
Topics: Administration, Cutaneous; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Patient Preference; Prospective Studies; Psoriasis; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2015 |
Will a single periarticular lidocaine-corticosteroid injection improve the clinical efficacy of intraarticular hyaluronic acid treatment of symptomatic knee osteoarthritis?
Topics: Activities of Daily Living; Aged; Anesthetics, Local; Anti-Inflammatory Agents; Betamethasone; Drug Therapy, Combination; Female; Humans; Hyaluronic Acid; Injections; Injections, Intra-Articular; Knee Joint; Lidocaine; Male; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Prospective Studies; Single-Blind Method; Treatment Outcome; Viscosupplements | 2016 |
Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Patient Preference; Pilot Projects; Psoriasis; Severity of Illness Index; Suspensions; Treatment Outcome | 2014 |
NAVS naphthalan for the treatment of oral mucosal diseases--a pilot study.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Betamethasone; Double-Blind Method; Female; Humans; Lichen Planus, Oral; Male; Naphthalenes; Ointments; Pain Measurement; Pilot Projects; Recurrence; Severity of Illness Index; Stomatitis, Aphthous; Treatment Outcome | 2014 |
Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris.
Topics: Adult; Aerosols; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Single-Blind Method; Ultrasonography; Young Adult | 2015 |
Finasteride Quantification in Human Plasma by High-Performance Liquid Chromatography Coupled to Electrospray Ionization Tandem Mass Spectrometry. Application to a Comparative Pharmacokinetics Study.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Adult; Betamethasone; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Finasteride; Humans; Limit of Detection; Male; Middle Aged; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Therapeutic Equivalency; Young Adult | 2015 |
Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population.
Topics: Administration, Topical; Adult; Asian People; Betamethasone; Calcitriol; China; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Safety; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Solutions; Treatment Outcome | 2016 |
A Randomized, Double-Blind, Placebo-Controlled Study of the Effect of a High-Potency Topical Corticosteroid After Sclerotherapy for Reticular and Telangiectatic Veins of the Lower Extremities.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Female; Humans; Lower Extremity; Middle Aged; Polidocanol; Polyethylene Glycols; Postoperative Care; Prospective Studies; Sclerosing Solutions; Sclerotherapy; Telangiectasis | 2015 |
Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.
Topics: Adult; Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Single-Blind Method; Treatment Outcome | 2016 |
Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST).
Topics: Adolescent; Adult; Aerosols; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Psoriasis; Skin; Treatment Outcome; Young Adult | 2015 |
Extracorporeal shock wave therapy versus corticosteroid injection in the treatment of trigger finger: a randomized controlled study.
Topics: Adult; Aged; Betamethasone; Extracorporeal Shockwave Therapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome; Trigger Finger Disorder | 2016 |
DFD-01, a Novel Medium Potency Betamethasone Dipropionate 0.05% Emollient Spray, Demonstrates Similar Efficacy to Augmented Betamethasone Dipropionate 0.05% Lotion for the Treatment of Moderate Plaque Psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Double-Blind Method; Drug Delivery Systems; Emollients; Female; Humans; Male; Middle Aged; Psoriasis; Treatment Outcome; Young Adult | 2016 |
Improvement in Extensive Moderate Plaque Psoriasis With a Novel Emollient Spray Formulation of Betamethasone Dipropionate 0.05.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Body Surface Area; Double-Blind Method; Emollients; Female; Glucocorticoids; Humans; Male; Middle Aged; Pharmaceutical Vehicles; Psoriasis; Skin; Treatment Outcome; Young Adult | 2016 |
Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO-ABLE study.
Topics: Adult; Aerosols; Betamethasone; Calcitriol; Female; Gels; Humans; Male; Middle Aged; Psoriasis | 2017 |
Aerosol Foam Formulation of Fixed Combination Calcipotriene Plus Betamethasone Dipropionate is Highly Efficacious in Patients With Psoriasis Vulgaris: Pooled Data From Three Randomized Controlled Studies.
Topics: Adolescent; Adult; Aerosols; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Drug Combinations; Drug Compounding; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Statistics as Topic; Treatment Outcome; Young Adult | 2016 |
The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoriasis Vulgaris: Results from the Randomized PSO-FAST Study.
Topics: Adult; Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Drug Compounding; Female; Health Status; Humans; Male; Psoriasis; Quality of Life | 2016 |
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis.
Topics: Adult; Aerosols; Betamethasone; Betamethasone Valerate; Calcitriol; Dermatologic Agents; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Single-Blind Method; Treatment Outcome | 2017 |
Comparison of the efficacy of lidocaine and betamethasone dipropionate in carpal tunnel syndrome injection.
Topics: Adrenal Cortex Hormones; Adult; Anesthetics, Local; Anti-Inflammatory Agents; Betamethasone; Carpal Tunnel Syndrome; Female; Humans; Lidocaine; Male; Middle Aged; Physical Examination; Steroids | 2017 |
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.
Topics: Administration, Cutaneous; Adult; Aerosols; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome | 2017 |
Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Biomarkers; Cell Differentiation; Clobetasol; Cytokines; Dermatitis, Atopic; Female; Humans; Hyperplasia; Male; Middle Aged; Placebo Effect; Psoriasis; Skin; Tacrolimus; Young Adult | 2017 |
A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP).
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Medication Adherence; Middle Aged; Patient Satisfaction; Physician-Patient Relations; Psoriasis; Quality of Life; Treatment Outcome; Young Adult | 2017 |
Best dilution of the best corticosteroid for intralesional injection in the treatment of localized alopecia areata in adults.
Topics: Adolescent; Adult; Alopecia Areata; Betamethasone; Dermoscopy; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Injections, Intralesional; Male; Middle Aged; Treatment Outcome; Triamcinolone Acetonide; Young Adult | 2017 |
A Comparative Study to Evaluate Epidermal Barrier Integrity of Psoriasis Patients Treated With Calcipotriene/Betamethasone Topical Suspension Versus Betamethasone Dipropionate 0.05% Lotion.
Topics: Administration, Cutaneous; Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Severity of Illness Index; Skin; Treatment Outcome; Water Loss, Insensible | 2017 |
Can an app supporting psoriasis patients improve adherence to topical treatment? A single-blind randomized controlled trial.
Topics: Administration, Topical; Betamethasone; Calcitriol; Dermatologic Agents; Humans; Medication Adherence; Mobile Applications; Psoriasis; Single-Blind Method | 2018 |
Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE study.
Topics: Absenteeism; Aerosols; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Gels; Humans; Medication Adherence; Middle Aged; Pruritus; Psoriasis; Quality of Life; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome | 2018 |
Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Prospective Studies; Psoriasis; Recurrence; Treatment Outcome; Ultrasonography; Ultraviolet Therapy; Young Adult | 2019 |
A Prospective, Open-Label Study Evaluating Adjunctive Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Psoriasis Patients With Inadequate Response to Biologic Therapy.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Biological Therapy; Calcitriol; Dermatologic Agents; Drug Compounding; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Treatment Outcome | 2018 |
The Effect of Calcipotriene-Betamethasone Dipropionate Aerosol Foam versus Vehicle on Target Lesions in Moderate Severity Plaque Psoriasis: Focus on Elbows and Knees
Topics: Adult; Aerosols; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Elbow Joint; Female; Humans; Knee Joint; Male; Middle Aged; Pilot Projects; Psoriasis; Severity of Illness Index; Treatment Outcome | 2019 |
Corticosteroid application prior to nickel exposure prevents contact dermatitis in sensitized individuals.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatitis, Allergic Contact; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Humans; Nickel; Patch Tests | 2020 |
Safety and efficacy of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam in adolescent patients (aged 12 to <17 years) with plaque psoriasis: results of a phase II, open-label trial.
Topics: Adolescent; Betamethasone; Calcitriol; Child; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2020 |
Topical rapamycin versus betamethasone dipropionate ointment for treating oral erosive lichen planus: a randomized, double-blind, controlled study.
Topics: Administration, Topical; Betamethasone; Double-Blind Method; Humans; Lichen Planus, Oral; Neoplasm Recurrence, Local; Ointments; Psoriasis; Sirolimus; Treatment Outcome | 2020 |
Effect of Calcipotriene/Betamethasone Dipropionate 0.005%/0.064% Foam on Target Lesions in Plaque Psoriasis:\
A Post-Hoc Analysis
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Double-Blind Method; Female; Humans; Male; Middle Aged; Psoriasis; Young Adult | 2020 |
Fixed combination of tazarotene and betamethasone dipropionate for treatment of psoriasis vulgaris: The result of a phase 3, multicenter, randomized controlled trial.
Topics: Betamethasone; Clobetasol; Dermatologic Agents; Double-Blind Method; Humans; Neoplasm Recurrence, Local; Nicotinic Acids; Psoriasis; Severity of Illness Index; Skin Cream; Treatment Outcome | 2020 |
Non-invasive clinical and microscopic evaluation of the response to treatment with clobetasol cream vs. calcipotriol/betamethasone dipropionate foam in mild to moderate plaque psoriasis: an investigator-initiated, phase IV, unicentric, open, randomized cl
Topics: Adult; Betamethasone; Calcitriol; Clobetasol; Dermatologic Agents; Humans; Male; Prospective Studies; Psoriasis; Treatment Outcome | 2021 |
PGAxBSA composite versus PASI: Comparison across disease severities and as therapeutic response measure for Cal/BD foam in plaque psoriasis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Body Surface Area; Calcitriol; Data Interpretation, Statistical; Dermatologic Agents; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Psoriasis; Severity of Illness Index; Treatment Outcome | 2020 |
Treating Scalp Psoriasis with Calcipotriene/Betamethasone Dipropionate Fixed-dose Combination Cutaneous Foam: Review of Phase 2 Data
Topics: Administration, Topical; Adolescent; Adult; Aerosols; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2020 |
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).
Topics: Administration, Cutaneous; Adult; Aerosols; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Secondary Prevention; Time Factors; Treatment Outcome; Young Adult | 2021 |
Efficacy and Safety of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam With Apremilast for Moderate Plaque Psoriasis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aerosols; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pruritus; Psoriasis; Quality of Life; Severity of Illness Index; Thalidomide; Treatment Outcome; Visual Analog Scale | 2020 |
Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled
Topics: Adult; Aged; Anti-Inflammatory Agents; Asian People; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Gels; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Scalp Dermatoses; Solutions; Treatment Outcome | 2020 |
Apremilast with Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis.
Topics: Administration, Cutaneous; Adult; Aerosols; Aged; Betamethasone; Calcitriol; Diarrhea; Drug Combinations; Drug Therapy, Combination; Female; Headache; Humans; Male; Middle Aged; Nausea; Pilot Projects; Psoriasis; Severity of Illness Index; Thalidomide; Treatment Outcome; Young Adult | 2020 |
Topical NAVS naphthalan for the treatment of oral lichen planus and recurrent aphthous stomatitis: A double blind, randomized, parallel group study.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Betamethasone; Female; Humans; Lichen Planus, Oral; Male; Middle Aged; Naphthalenes; Quality of Life; Stomatitis, Aphthous | 2021 |
A Phase 3, Randomized Trial Demonstrating the Improved Efficacy and Patient Acceptability of Fixed Dose Calcipotriene and Betamethasone Dipropionate Cream.
Topics: Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Skin Cream; Treatment Outcome | 2021 |
Four-Week Daily Calcipotriene/Betamethasone Dipropionate Foam Is Highly Efficacious in Patients With Psoriasis (PSO-LONG Lead-in Phase).
Topics: Administration, Cutaneous; Adult; Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome | 2021 |
The Effect on BSA of Proactive Management versus Reactive Management of Psoriasis With Fixed-Dose Cal/BD Foam in the PSO-LONG Study.
Topics: Aerosols; Betamethasone; Body Surface Area; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Humans; Maintenance Chemotherapy; Psoriasis; Quality of Life; Recurrence; Remission Induction; Secondary Prevention; Severity of Illness Index; Treatment Outcome | 2021 |
Clinical, patient and estimated cost benefits of proactive management versus reactive management with calcipotriol/betamethasone dipropionate foam for the treatment of plaque psoriasis in Finland.
Topics: Aerosols; Betamethasone; Calcitriol; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Finland; Humans; Psoriasis; Recurrence; Treatment Outcome | 2022 |
Pooled Analysis Demonstrating Superior Patient- Reported Psoriasis Treatment Outcomes for Calcipotriene/ Betamethasone Dipropionate Cream Versus Suspension/Gel.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Patient Reported Outcome Measures; Psoriasis; Quality of Life; Treatment Outcome | 2022 |
Investigating the efficacy and safety of calcipotriol/betamethasone dipropionate foam and laser microporation for psoriatic nail disease-A hybrid trial using a smartphone application, optical coherence tomography, and patient-reported outcome measures.
Topics: Aerosols; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Lasers; Mobile Applications; Nail Diseases; Patient Reported Outcome Measures; Psoriasis; Smartphone; Tomography, Optical Coherence; Treatment Outcome | 2022 |
Efficacy and Safety of Calcipotriene/Betamethasone Dipropionate Foam in the Treatment of Psoriasis in Skin of Color.
Topics: Adult; Aerosols; Betamethasone; Dermatologic Agents; Drug Combinations; Excipients; Humans; Psoriasis; Skin; Skin Pigmentation; Treatment Outcome | 2023 |
Efficacy, Convenience, and Safety of Calcipotriene-Betamethasone Dipropionate Cream in Skin of Color Patients With Plaque Psoriasis.
Topics: Adult; Betamethasone; Dermatologic Agents; Drug Combinations; Emollients; Excipients; Humans; Psoriasis; Skin Pigmentation; Treatment Outcome | 2023 |
Randomized Phase 3 trial demonstrating high efficacy, favourable safety and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Emollients; Humans; Psoriasis; Treatment Outcome | 2023 |
261 other study(ies) available for betamethasone and betamethasone-17,21-dipropionate
| Article | Year |
|---|---|
Computer-aided studies of the structure-activity relationships between the structure of some steroids and their antiinflammatory activity.
Topics: Anti-Inflammatory Agents; Humans; Numerical Analysis, Computer-Assisted; Steroids; Structure-Activity Relationship; Vasoconstriction | 1986 |
Structure-activity relationships in the antiinflammatory steroids: a pattern-recognition approach.
Topics: Animals; Anti-Inflammatory Agents; Drug Synergism; Granuloma; Humans; Models, Chemical; Rats; Steroids; Structure-Activity Relationship; Vasoconstriction | 1983 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Betamethasone dipropionate: a new topical agent for the treatment of psoriasis.
Topics: Adult; Aged; Betamethasone; Drug Evaluation; Female; Humans; Male; Middle Aged; Psoriasis | 1975 |
[Diprosone cream: its value in daily dermatologic practice].
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Cresols; Drug Combinations; Drug Evaluation; Eczema; Glucocorticoids; Humans; Neomycin; Neurodermatitis; Ointments; Parakeratosis; Psoriasis; Skin Diseases | 1975 |
Immunohistochemical study on the pattern of 50 kd cytokeratin in psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Anthralin; Anti-Inflammatory Agents; Betamethasone; Epidermis; Female; Fluorescent Antibody Technique; Glucocorticoids; Humans; Immunoenzyme Techniques; Keratins; Male; Methoxsalen; Middle Aged; Molecular Weight; Psoriasis; PUVA Therapy; Skin | 1992 |
Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Biological Assay; Biological Availability; Chromatography, High Pressure Liquid; Feasibility Studies; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Skin; Vasoconstriction | 1992 |
Facial blanching caused by superpotent corticosteroids.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Seborrheic; Facial Dermatoses; Glucocorticoids; Humans; Male; Pigmentation Disorders | 1991 |
Exacerbation of tinea corporis during treatment with 1% clotrimazole/0.05% betamethasone diproprionate (Lotrisone)
Topics: Abscess; Betamethasone; Child; Clotrimazole; Dermatomycoses; Drug Combinations; Female; Granuloma; Humans; Knee; Tinea | 1991 |
Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Female; Glucocorticoids; Histamine; Humans; Male; Mast Cells; Middle Aged; Urticaria Pigmentosa | 1991 |
[Vipsogal in the therapy of psoriasis].
Topics: Adult; Aged; Betamethasone; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Fluocinonide; Gentamicins; Humans; Male; Middle Aged; Ointments; Pantothenic Acid; Psoriasis; PUVA Therapy | 1990 |
A vegetating variety of pemphigus foliaceus.
Topics: Acantholysis; Administration, Topical; Aged; Anti-Inflammatory Agents; Betamethasone; Clobetasol; Fluorescent Antibody Technique; Glucocorticoids; Humans; Immunoglobulin G; Male; Pemphigus | 1990 |
[Pseudoatrophic pityriasis versicolor].
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Betamethasone; Glucocorticoids; Humans; Male; Tinea Versicolor | 1990 |
Guidelines for using superpotent topical steroids.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Clobetasol; Glucocorticoids; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Skin Diseases | 1990 |
Histological study of mast cells in the actively sensitized guinea pig lung and after challenge: effect of a corticosteroid.
Topics: Adrenal Cortex Hormones; Animals; Betamethasone; Bronchi; Cell Count; Guinea Pigs; Hypersensitivity; Male; Mast Cells; Ovalbumin | 1990 |
Psoriasis treatment with betamethasone dipropionate using short-term application and short-term occlusion.
Topics: Administration, Topical; Betamethasone; Double-Blind Method; Humans; Occlusive Dressings; Psoriasis; Random Allocation; Time Factors | 1986 |
Topical corticosteroids delay the proliferative response to sellotape stripping.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Betamethasone; Cell Division; DNA; Female; Flow Cytometry; Humans; Hydrocortisone; Interphase; Keratinocytes; Male; Skin; Staining and Labeling | 1989 |
Development of glucocorticosteroids with enhanced ratio between topical and systemic effects.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Biotransformation; Budesonide; Dose-Response Relationship, Drug; Humans; Hydrocortisone; Liver; Male; Mice; Pregnenediones; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1989 |
Sclerotherapy: review of results and complications in 200 patients.
Topics: Betamethasone; Contraceptives, Oral; Female; Heparin; Humans; Pigmentation Disorders; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sodium Chloride; Varicose Veins | 1989 |
Immediate and delayed sensitivity to chlorocresol.
Topics: Adult; Betamethasone; Cresols; Dermatitis, Occupational; Drug Eruptions; Female; Humans; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Ointments; Skin Tests | 1987 |
Chronic benign familial pemphigus.
Topics: Adult; Betamethasone; Chronic Disease; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluorescent Antibody Technique; Gentamicins; Humans; Male; Middle Aged; Pemphigus; Prednisone; Seasons; Skin | 1988 |
The effect of modulating the synthesis of arachidonic acid cascade products on HSV lesion recurrence.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Betamethasone; Chlorpromazine; Dexamethasone; Ear; Herpes Simplex; Masoprocol; Meclofenamic Acid; Mice; Recurrence | 1987 |
[Subacute cutaneous lupus erythematosus. Treatment with sulfone].
Topics: Acute Disease; Aged; Betamethasone; Humans; Lupus Erythematosus, Cutaneous; Male; Sulfones | 1987 |
[Use of external medicinal preparations containing betamethasone in the treatment of chronic dermatoses].
Topics: Betamethasone; Drug Combinations; Gentamicins; Humans; Ointments; Salicylates; Skin Diseases | 1987 |
Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (Lotrisone cream)
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Clotrimazole; Drug Combinations; Female; Glucocorticoids; Humans; Pregnancy; Skin; Time Factors; Tinea | 1987 |
Evaluation of triacontanol-containing compounds as anti-inflammatory agents using guinea pig models.
Topics: Animals; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Contact; Fatty Alcohols; Guinea Pigs; Lymphocyte Activation | 1987 |
Aggressive topical corticosteroid therapy: a novel approach to mast-cell-dependent cutaneous disorders.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Glucocorticoids; Humans; Mast Cells; Skin; Triamcinolone Acetonide; Urticaria Pigmentosa | 1987 |
Majocchi's granuloma (due to therapy with steroid and occlusion).
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Glucocorticoids; Humans; Occlusive Dressings; Tinea | 1986 |
Transepidermal elimination following the use of a topical adrenal steroid.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Betamethasone; Female; Glucocorticoids; Humans; Psoriasis; Skin | 1985 |
Effect of crystallinity on the percutaneous absorption of corticosteroid. II. Chemical activity and biological activity.
Topics: Adrenal Cortex Hormones; Adult; Betamethasone; Chemical Phenomena; Chemistry; Chemistry, Pharmaceutical; Crystallization; Humans; Hydrocortisone; Male; Skin Absorption | 1985 |
RU 486 inhibits peripheral effects of glucocorticoids in humans.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Clobetasol; Double-Blind Method; Estrenes; Humans; Hydrocortisone; Male; Mifepristone; Random Allocation; Receptors, Glucocorticoid; Skin; Vasoconstriction | 1985 |
Jellyfish stings.
Topics: Betamethasone; Bites and Stings; Cnidaria; Drug Combinations; Humans; Promethazine; Scyphozoa | 1984 |
Effect of glucocorticoids and gamma radiation on epidermal Langerhans cells.
Topics: Adenosine Triphosphatases; Animals; Betamethasone; Cell Membrane; Gamma Rays; Glucocorticoids; Guinea Pigs; Histocompatibility Antigens Class II; Langerhans Cells | 1984 |
A change in the adrenocortical response in perinatal rat offspring given betamethasone 17,21-dipropionate.
Topics: Adrenal Cortex; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Animals, Newborn; Betamethasone; Corticosterone; Female; Hypertrophy; Hypophysectomy; Maternal-Fetal Exchange; Organ Size; Pituitary Gland; Pregnancy; Rats | 1981 |
Systemic effects of 0.064% betamethasone dipropionate ointment and cream by simple application - with emphasis upon the suppression of adrenocortical functions.
Topics: Adrenal Cortex; Betamethasone; Depression, Chemical; Dose-Response Relationship, Drug; Hormone Antagonists; Humans; Hydrocortisone; Ointments; Skin Diseases | 1983 |
Effect of glucocorticosteroids on epidermal Langerhans cells.
Topics: Adenosine Triphosphatases; Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Cell Count; Epidermis; Glucocorticoids; Guinea Pigs; Histocompatibility Antigens Class II; Langerhans Cells; Skin Diseases | 1982 |
[Acanthosis nigricans induced by local nicotinic acid].
Topics: Acanthosis Nigricans; Administration, Topical; Betamethasone; Female; Humans; Infant; Nicotinyl Alcohol; Pyridines | 1984 |
Diprolene cream in the treatment of severe or resistant corticosteroid-responsive dermatoses.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Atopic; Drug Administration Schedule; Drug Tolerance; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Time Factors | 1984 |
Treatment of severe or resistant corticosteroid-responsive dermatoses with Diprolene cream.
Topics: Adult; Aged; Betamethasone; Dermatitis, Atopic; Drug Resistance; Female; Humans; Male; Middle Aged; Ointments; Propylene Glycols; Psoriasis; Skin Diseases | 1984 |
Betamethasone dipropionate and salicylic acid lotion for nonscalp dermatoses.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Child; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Eczema; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Salicylates; Salicylic Acid; Skin Diseases | 1983 |
[Placental transfer and distribution of betamethasone 17,21-dipropionate in various regions of the brain of pregnant rats and mice (author's transl)].
Topics: Animals; Autoradiography; Betamethasone; Brain; Female; Fetus; Maternal-Fetal Exchange; Mice; Placenta; Pregnancy; Rats; Tissue Distribution; Tritium | 1981 |
Correlation between metabolism of betamethasone 17,21-dipropionate and adrenal hypertrophy in rat fetuses.
Topics: Adrenal Glands; Animals; Betamethasone; Chromatography, High Pressure Liquid; Female; Hypertrophy; Maternal-Fetal Exchange; Mice; Organ Size; Pregnancy; Rats; Tissue Distribution | 1981 |
[Adrenal insufficiency and iatrogenic Cushing's syndrome by cutaneous absorption of corticosteroids in an 8 month old infant].
Topics: Adrenal Insufficiency; Betamethasone; Cushing Syndrome; Erythema; Female; Humans; Hydrocortisone; Iatrogenic Disease; Infant; Skin Absorption | 1980 |
[Effects of betamethasone 17-propionate and betamethasone on hypothalamo-pituitary-adrenal cortex axis in rats (author's transl)].
Topics: Animals; Betamethasone; Corticosterone; Depression, Chemical; Female; Hypothalamo-Hypophyseal System; Injections, Intravenous; Injections, Subcutaneous; Pituitary-Adrenal System; Rats | 1980 |
Efficacy and tolerance of betamethasone dipropionate propylene glycol for resistant psoriasis and other resistant steroid-responsive dermatoses.
Topics: Adolescent; Adult; Aged; Betamethasone; Dermatitis, Atopic; Drug Resistance; Female; Humans; Male; Middle Aged; Prurigo; Psoriasis | 1981 |
The effect of betamethasone dipropionate glycol ointment 0.05% (diprosone O.V.) on adrenocortical function.
Topics: Administration, Topical; Adolescent; Adrenal Cortex; Adult; Anti-Inflammatory Agents; Betamethasone; Dermatitis; Female; Humans; Hydrocortisone; Male; Middle Aged; Ointments | 1981 |
[The specific biological activity of the glucocorticoid betamethasone 17,21-dipropionate].
Topics: Anaphylaxis; Animals; Betamethasone; Body Weight; Circadian Rhythm; Corticosterone; Female; Guinea Pigs; Hypothalamo-Hypophyseal System; Inflammation; Liver; Male; Mice; Rabbits; Rats; Spleen; Thymus Gland; Tryptophan Oxygenase | 1980 |
Treatment of generalized bullous pemphigoid with topical corticosteroids.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Clobetasol; Female; Glucocorticoids; Humans; Male; Middle Aged; Pemphigoid, Bullous; Triamcinolone Acetonide | 1995 |
Failure of clotrimazole-betamethasone dipropionate cream in treatment of Microsporum canis infections.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Child; Clotrimazole; Dermatomycoses; Drug Combinations; Female; Glucocorticoids; Humans; Male; Microsporum; Ointments; Treatment Failure | 1995 |
Interleukin-6 and tumour necrosis factor levels decrease in the suction blister fluids of psoriatic patients during effective therapy.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Blister; Combined Modality Therapy; Exudates and Transudates; Female; Follow-Up Studies; Glucocorticoids; Humans; Interleukin-6; Middle Aged; Ointments; Psoriasis; Salicylates; Salicylic Acid; Skin; Tumor Necrosis Factor-alpha; Ultraviolet Therapy | 1994 |
Cutaneous histiocytosis with Langerhans cell features induced by scabies: a case report.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Biopsy; Glucocorticoids; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Microscopy, Electron; Permethrin; Pyrethrins; Scabies | 1994 |
Use of short-course class 1 topical glucocorticoid under occlusion for the rapid control of erythrodermic psoriasis.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Exfoliative; Female; Glucocorticoids; Humans; Male; Middle Aged; Occlusive Dressings; Psoriasis; Time Factors | 1994 |
Topical 0.050% betamethasone dipropionate. Pharmacokinetic and pharmacodynamic dose-response studies in humans.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Chemistry Techniques, Analytical; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Male; Skin | 1994 |
Comparison of the bioactivity of mometasone furoate 0.1% fatty cream, betamethasone dipropionate 0.05% cream and betamethasone valerate 0.1% cream in humans. Inhibition of UV-B-induced inflammation monitored by laser Doppler blood flowmetry.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Erythema; Glucocorticoids; Humans; Laser-Doppler Flowmetry; Middle Aged; Mometasone Furoate; Ointments; Pharmaceutical Vehicles; Pregnadienediols; Regional Blood Flow; Skin; Ultraviolet Rays | 1993 |
Kaposi's sarcoma with visceral involvement after intraarticular and epidural injections of corticosteroids.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Glucocorticoids; Humans; Injections, Intra-Articular; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged; Sarcoma, Kaposi; Ulnar Nerve Compression Syndromes | 1993 |
Iatrogenic Cushing's syndrome in a dog from owner's topical corticosteroid.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Cushing Syndrome; Dog Diseases; Dogs; Glucocorticoids | 1993 |
Swine as a model of skin inflammation. Phospholipase A2-induced inflammation.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Disease Models, Animal; Drug Eruptions; Foot; Glucocorticoids; Inflammation; Injections; Injections, Intradermal; Mice; Phospholipases A; Phospholipases A2; Swine | 1993 |
[A case for diagnosis: erosive pustular dermatosis of the scalp].
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Betamethasone; Burns; Glucocorticoids; Humans; Male; Scalp Dermatoses; Skin Diseases, Vesiculobullous | 1995 |
Pemphigoid and pemphigus foliaceus successfully treated with topical corticosteroids.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Clobetasol; Dexamethasone; Female; Fluocinonide; Glucocorticoids; Humans; Leg Dermatoses; Male; Middle Aged; Ointments; Pemphigoid, Bullous; Pemphigus; Triamcinolone | 1996 |
Tinea corporis due to Trichophyton tonsurans Malmsten--report of a patient from Zaire.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Betamethasone; Clotrimazole; Democratic Republic of the Congo; Female; Humans; Itraconazole; Naphthalenes; Recurrence; Terbinafine; Tinea; Trichophyton | 1997 |
The effects of betamethasone derivatives on endotoxin-induced uveitis in guinea pigs.
Topics: Animals; Anti-Inflammatory Agents; Aqueous Humor; Betamethasone; Betamethasone Valerate; Dinoprostone; Endotoxins; Escherichia coli; Guinea Pigs; Leukocyte Count; Lipopolysaccharides; Male; Uveitis | 1997 |
In vitro release of betamethasone dipropionate from petrolatum-based ointments.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Chromatography, High Pressure Liquid; Diffusion; Glucocorticoids; Ointment Bases; Ointments; Petrolatum | 1996 |
Permeability barrier abnormality of hairless mouse epidermis after topical corticosteroid: characterization of stratum corneum lipids by ruthenium tetroxide staining and high-performance thin-layer chromatography.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Chromatography, Thin Layer; Epidermis; Glucocorticoids; Lipids; Male; Mice; Mice, Hairless; Permeability; Ruthenium Compounds | 1998 |
Nondermatologists are more likely than dermatologists to prescribe antifungal/corticosteroid products: an analysis of office visits for cutaneous fungal infections, 1990-1994.
Topics: Administration, Topical; Ambulatory Care; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Clotrimazole; Cost Savings; Cost-Benefit Analysis; Dermatology; Dermatomycoses; Drug Combinations; Drug Costs; Family Practice; Glucocorticoids; Humans; Ketoconazole; Office Visits; Pediatrics; Practice Patterns, Physicians'; Tinea; Treatment Outcome | 1998 |
Determination of betamethasone dipropionate and salicylic acid in pharmaceutical preparations by high-performance liquid chromatography.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Glucocorticoids; Humans; Ointments; Salicylic Acid; Solutions; Spectrophotometry, Ultraviolet | 1998 |
Persistent hiccups associated with intraarticular corticosteroid injection.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Glucocorticoids; Hiccup; Humans; Injections, Intra-Articular; Male; Methotrimeprazine; Spondylitis, Ankylosing | 1999 |
Crusted (Norwegian) scabies induced by use of topical corticosteroids and treated successfully with ivermectin.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Glucocorticoids; Humans; Infant; Insecticides; Ivermectin; Male; Scabies | 1999 |
Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Betamethasone; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dermatologic Agents; Diffusion; Evaluation Studies as Topic; Excipients; Glucocorticoids; Indicators and Reagents; Ointments; Pharmaceutical Preparations; United States; United States Food and Drug Administration | 1999 |
Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians.
Topics: Administration, Topical; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Betamethasone; Child, Preschool; Clotrimazole; Drug Utilization; Glucocorticoids; Humans; Infant; Infant, Newborn; Skin Diseases | 1999 |
Comparison between micellar electrokinetic chromatography and HPLC for the determination of Betamethasone Dipropionate, Clotrimazole and their related substances.
Topics: Administration, Topical; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Chromatography, High Pressure Liquid; Chromatography, Micellar Electrokinetic Capillary; Clotrimazole; Feasibility Studies; Glucocorticoids; Quality Control; Reproducibility of Results | 1999 |
Hiccups with betamethasone dipropionate.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Glucocorticoids; Hiccup; Humans; Male; Middle Aged | 2000 |
In vitro compatibility of tazarotene with other topical treatments of psoriasis.
Topics: Administration, Topical; Betamethasone; Calcitriol; Clobetasol; Dermatologic Agents; Drug Evaluation, Preclinical; Drug Incompatibility; Fluocinonide; In Vitro Techniques; Mometasone Furoate; Nicotinic Acids; Pregnadienediols; Psoriasis | 2000 |
Use of clotrimazole/betamethasone diproprionate by family physicians.
Topics: Administration, Topical; Adult; Age Factors; Ambulatory Care; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Candidiasis; Child, Preschool; Clotrimazole; Cost Savings; Demography; Dermatology; Drug Combinations; Drug Costs; Drug Prescriptions; Drug Utilization; Family Practice; Female; Glucocorticoids; Humans; Male; Middle Aged; Mycoses; Pediatrics; United States | 2000 |
Evaluation of safety and efficacy of supirocin-B (mupirocin 2% + betamethasone dipropionate 0.05%) in infected dermatoses--a post marketing study.
Topics: Betamethasone; Drug Combinations; Humans; India; Mupirocin; Ointments; Product Surveillance, Postmarketing; Pyoderma; Staphylococcal Skin Infections; Streptococcal Infections; Treatment Outcome | 2000 |
Bias shown in study of better care for patients with skin disease?
Topics: Betamethasone; Clotrimazole; Conflict of Interest; Dermatologic Agents; Humans; Physicians, Family; Practice Patterns, Physicians'; Quality of Health Care; Skin Diseases | 2001 |
[Dyshidrosis and acral purpura during polymorphic dermatitis in pregnancy: 2 cases].
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Antipruritics; Betamethasone; Biopsy; Drug Therapy, Combination; Eczema, Dyshidrotic; Female; Glucocorticoids; Humans; Hydroxyzine; Parity; Pregnancy; Pregnancy Complications; Pruritus; Purpura | 2001 |
[Pemphigoid gestationis: treatment by topical class I corticosteroid].
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Betamethasone; Clobetasol; Female; Fluorescent Antibody Technique, Direct; Glucocorticoids; Humans; Pemphigoid, Bullous; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Treatment Outcome | 2001 |
Topical therapy with fluorinated and non-fluorinated corticosteroids in patients with atopic dermatitis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Atopic; Glucocorticoids; Humans; Mometasone Furoate; Pregnadienediols; Steroids, Fluorinated | 2001 |
Severe vulvovaginitis associated with intravaginal nystatin therapy.
Topics: Administration, Intravaginal; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Candidiasis; Edema; Erythema; Female; Humans; Hydrocortisone; Middle Aged; Nystatin; Vulvovaginitis | 2001 |
A topical steroid without an antibiotic cures external otitis efficiently: a study in an animal model.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Disease Models, Animal; Ear, External; Glucocorticoids; Male; Otitis Externa; Rats; Rats, Sprague-Dawley | 2001 |
Persistent and recurrent tinea corporis in children treated with combination antifungal/ corticosteroid agents.
Topics: Administration, Topical; Allylamine; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Child; Child, Preschool; Clotrimazole; Drug Therapy, Combination; Glucocorticoids; Humans; Infant; Recurrence; Retrospective Studies; Tinea; Treatment Failure | 2003 |
[Effect of admixture of betamethasone butyrate propionate ointment on preservative efficacy].
Topics: Betamethasone; Drug Contamination; Drug Stability; Drug Storage; Emulsions; Ointments; Parabens; Preservatives, Pharmaceutical | 2002 |
Intertriginous granular parakeratosis responsive to potent topical corticosteroids.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Axilla; Betamethasone; Female; Glucocorticoids; Groin; Humans; Male; Middle Aged; Ointments; Parakeratosis | 2003 |
O'Brien's actinic granuloma in association with prolonged doxycycline phototoxicity.
Topics: Administration, Cutaneous; Adult; Antimalarials; Betamethasone; Diagnosis, Differential; Doxycycline; Granuloma; Humans; Malaria; Male; Neck; Skin Diseases; Sunlight | 2003 |
[New ointment with vitamin D derivative and corticoid. Psoriasis therapy combined].
Topics: Betamethasone; Calcitriol; Clinical Trials as Topic; Dermatologic Agents; Drug Combinations; Humans; Ointments; Psoriasis | 2003 |
Adrenal insufficiency and diabetes mellitus secondary to the use of topical corticosteroids for cosmetic purpose.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adrenal Insufficiency; Africa South of the Sahara; Anti-Inflammatory Agents; Betamethasone; Diabetes Mellitus; Female; France; Glucocorticoids; Humans; Middle Aged | 2003 |
Topical betamethasone: a double blind study.
Topics: Adrenal Cortex Hormones; Betamethasone; Dermatology; Double-Blind Method; Humans | 1963 |
[TOPICAL BETAMETHASONE VALERATE IN ALLERGIC DISEASES].
Topics: Betamethasone; Betamethasone Valerate; Drug Therapy; Humans; Hypersensitivity; Immune System Diseases | 1965 |
Once daily application of a combination of calcipotriol and betamethasone dipropionate (Dovobet, Daivobet) for the treatment of psoriasis.
Topics: Adult; Betamethasone; Calcitriol; Confidence Intervals; Data Interpretation, Statistical; Dermatologic Agents; Double-Blind Method; Drug Combinations; Humans; Multicenter Studies as Topic; Patient Compliance; Prospective Studies; Psoriasis; Randomized Controlled Trials as Topic; Severity of Illness Index; Time Factors | 2003 |
Topical corticosteroid allergy in an urban Australian centre.
Topics: Administration, Topical; Adult; Australia; Betamethasone; Betamethasone Valerate; Budesonide; Dermatitis, Allergic Contact; Dermatitis, Occupational; Drug Utilization; Female; Glucocorticoids; Humans; Hydrocortisone; Male; Middle Aged; Patch Tests; Practice Patterns, Physicians'; Prevalence; Retrospective Studies; Triamcinolone Acetonide | 2004 |
Glaucoma from topical corticosteroids to the eyelids.
Topics: Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Blepharitis; Dermatitis, Allergic Contact; Eyelids; Glaucoma; Glucocorticoids; Humans; Hydrocortisone; Intraocular Pressure; Male; Middle Aged; Mometasone Furoate; Pregnadienediols; Psoriasis | 2004 |
Analysis of factors associated with prescription of a potentially inappropriate combination dermatological medication among US outpatient physicians.
Topics: Administration, Topical; Adolescent; Adult; Betamethasone; Child; Child, Preschool; Clotrimazole; Dermatologic Agents; Drug Prescriptions; Drug Utilization Review; Female; Humans; Medication Errors; Physician's Role; Primary Health Care; Statistics as Topic; United States; Writing | 2004 |
[Corticoid therapy in asthma. Smaller particles--bigger effect].
Topics: Aerosol Propellants; Anti-Asthmatic Agents; Asthma; Betamethasone; Glucocorticoids; Humans; Hydrocarbons, Fluorinated; Nebulizers and Vaporizers; Particle Size; Solutions | 2004 |
Bioavailability of betamethasone dipropionate when combined with calcipotriol.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Biological Availability; Calcitriol; Dermatologic Agents; Drug Combinations; Drug Interactions; Humans; Male; Middle Aged; Pilot Projects; Psoriasis | 2004 |
TOPICAL BETAMETHASONE IN TREATMENT OF ALLERGIC AND INFLAMMATORY DERMATOSES.
Topics: Betamethasone; Dermatitis; Dermatitis, Atopic; Dermatitis, Contact; Humans; Neomycin | 1964 |
[Our experience using triderm for the treatment of external otitis].
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Antifungal Agents; Aspergillus; Bacteria; Betamethasone; Candida; Clotrimazole; Drug Combinations; Gentamicins; Humans; Otitis Externa; Time Factors; Treatment Outcome | 2004 |
Glaucoma induced by periorbital topical steroid use--a rare complication.
Topics: Administration, Cutaneous; Adult; Betamethasone; Drug Administration Schedule; Eczema; Eyelid Diseases; Facial Dermatoses; Female; Glaucoma; Glucocorticoids; Humans; Vision Disorders | 2004 |
[How I treat ...scalp psoriasis].
Topics: Betamethasone; Humans; Psoriasis; Scalp Dermatoses | 2004 |
Development of a new formulation combining calcipotriol and betamethasone dipropionate in an ointment vehicle.
Topics: Administration, Topical; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Denmark; Drug Combinations; Drug Compounding; Drug Design; Humans; Ointments; Permeability; Pharmaceutical Vehicles; Skin; Solubility | 2004 |
Intralesional steroid injection for management of acute idiopathic dacryoadenitis: a preliminary result.
Topics: Acute Disease; Adolescent; Adult; Betamethasone; Child; Dacryocystitis; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intralesional; Male; Ophthalmic Solutions; Recurrence; Tomography, X-Ray Computed | 2005 |
Death by oral ingestion of iodine.
Topics: Administration, Oral; Aged; Betamethasone; Corrosion; Emergency Medicine; Fatal Outcome; Female; Gastrointestinal Tract; Humans; Iodine; Poisoning | 2005 |
External otitis caused by infection with Pseudomonas aeruginosa or Candida albicans cured by use of a topical group III steroid, without any antibiotics.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Betamethasone; Candidiasis; Colony-Forming Units Assay; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ear Canal; Hydrocortisone; Male; Otitis Externa; Oxytetracycline; Polymyxin B; Pseudomonas Infections; Rats; Treatment Outcome | 2005 |
[Leg ulcers: peri-ulcerous dermatitis].
Topics: Bandages; Betamethasone; Causality; Dermatitis; Emollients; Humans; Leg Ulcer; Male; Nursing Assessment; Physical Examination; Skin Care; Ultrasonography, Doppler | 2005 |
Once daily vs. twice daily applications of topical treatments in psoriasis.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Humans; Psoriasis | 2005 |
Treatment of guttate psoriasis with a new two-compound product containing calcipotriol and betamethasone dipropionate.
Topics: Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Ointments; Psoriasis | 2005 |
Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasis.
Topics: Adult; Betamethasone; Calcitriol; Clinical Trials, Phase III as Topic; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prospective Studies; Psoriasis; Randomized Controlled Trials as Topic; Reproducibility of Results; Treatment Outcome | 2006 |
Generalized pustular psoriasis complicated by acute respiratory distress syndrome.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Male; Middle Aged; Psoriasis; Respiratory Distress Syndrome | 2006 |
Potent corticosteroids inhibit lipogenesis in sebaceous glands.
Topics: Animals; Anti-Inflammatory Agents; Awards and Prizes; Betamethasone; Cell Differentiation; Lipogenesis; Mice; Ointments; Sebaceous Glands; Sebum | 2006 |
A 30-year history of CD4+ vesiculo-bullous mycosis fungoides and multiple visceral malignancies.
Topics: Adenocarcinoma; Administration, Cutaneous; Aged; Aged, 80 and over; Betamethasone; Carcinoma, Transitional Cell; CD4 Antigens; Colorectal Neoplasms; Diagnosis, Differential; Female; Humans; Lung Neoplasms; Mycosis Fungoides; Skin Neoplasms; Urinary Bladder Neoplasms | 2007 |
Treatment of scalp psoriasis with betamethasone dipropionate and calcipotriol two-compound product.
Topics: Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2007 |
Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?
Topics: Anti-Inflammatory Agents; Betamethasone; Biological Products; Calcitriol; Dermatologic Agents; Drug Administration Routes; Humans; Psoriasis; Severity of Illness Index; Skin Diseases; Treatment Outcome | 2007 |
Dermacase. Atrophic patches.
Topics: Adult; Atrophy; Betamethasone; Betamethasone Valerate; Female; Glucocorticoids; Humans; Skin | 2006 |
Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Antigens, CD; Betamethasone; Biopsy; Calcitriol; Cell Proliferation; Dermatologic Agents; Drug Therapy, Combination; Epidermis; Female; Humans; Keratinocytes; Low-Level Light Therapy; Male; Ointments; Psoriasis; Skin; T-Lymphocytes; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer; Treatment Outcome | 2007 |
Advances in first-line topical therapies: the role of a 2-compound ointment for psoriasis vulgaris.
Topics: Administration, Topical; Adrenal Cortex Hormones; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Humans; Ointments; Psoriasis | 2007 |
A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice.
Topics: Adrenal Cortex Hormones; Allergens; Animals; Betamethasone; Dermatitis, Atopic; Dermatophagoides farinae; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Immunoglobulin E; Immunosuppressive Agents; Interferon-gamma; Interleukin-13; Interleukin-5; Lymph Nodes; Mice; Reproducibility of Results; Skin; Tacrolimus | 2007 |
[Paclitaxel-induced lupus].
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antineoplastic Agents, Phytogenic; Betamethasone; Biopsy; Drug Therapy, Combination; Erythropoietin; Female; Humans; Lupus Erythematosus, Cutaneous; Ovarian Neoplasms; Paclitaxel; Recombinant Proteins; Recurrence; Skin; Treatment Outcome | 2007 |
First case series on the use of calcipotriol-betamethasone dipropionate for morphoea.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Female; Humans; Male; Middle Aged; Scleroderma, Localized; Treatment Outcome | 2007 |
Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Quality-Adjusted Life Years; Scotland; State Medicine; Treatment Outcome | 2007 |
Postzoster cutaneous pseudolymphoma in a patient with B-cell chronic lymphocytic leukaemia.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Diagnosis, Differential; Herpes Zoster; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Pseudolymphoma; Skin Diseases | 2007 |
The role of sacroiliac joint dysfunction in the genesis of low back pain: the obvious is not always right.
Topics: Anesthetics, Local; Anti-Inflammatory Agents; Betamethasone; Bupivacaine; Female; Fluoroscopy; Glucocorticoids; Humans; Intervertebral Disc Displacement; Joint Diseases; Low Back Pain; Magnetic Resonance Imaging; Male; Middle Aged; Pain Measurement; Radiography, Interventional; Sacroiliac Joint; Tomography, X-Ray Computed | 2007 |
[Childhood actinic lichen planus (6 cases)].
Topics: Adolescent; Anti-Inflammatory Agents; Antimalarials; Betamethasone; Child; Child, Preschool; Female; Humans; India; Infant, Newborn; Kuwait; Lichen Planus; Male; Photosensitivity Disorders; Recurrence; Retrospective Studies; Seasons; Sunscreening Agents; Time Factors; Treatment Outcome; Tunisia | 2008 |
Hyperkeratosis lenticularis perstans (Flegel's disease) - successful treatment with topical corticosteroids.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Biopsy; Female; Humans; Keratosis; Leg Dermatoses; Middle Aged | 2008 |
[Pruritic urticarial papules and plaques of pregnancy].
Topics: Adult; Anti-Inflammatory Agents; Antipruritics; Betamethasone; Female; Humans; Hydrocortisone; Hydroxyzine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Pruritus; Urticaria; Young Adult | 2008 |
Solitary mastocytoma occurring at a site of trauma.
Topics: Anti-Inflammatory Agents; Betamethasone; Birth Injuries; Female; Humans; Infant; Infant, Newborn; Mastocytoma, Skin; Proto-Oncogene Proteins c-kit; Thigh; Treatment Outcome; Wound Healing | 2009 |
Rapid structure elucidation of drug degradation products using mechanism-based stress studies in conjunction with LC-MS(n) and NMR spectroscopy: identification of a photodegradation product of betamethasone dipropionate.
Topics: Anti-Inflammatory Agents; Betamethasone; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug Stability; Magnetic Resonance Spectroscopy; Mass Spectrometry | 2009 |
Development and validation of a stability-indicating HPLC method for simultaneous determination of salicylic acid, betamethasone dipropionate and their related compounds in Diprosalic Lotion.
Topics: Anti-Inflammatory Agents; Betamethasone; Chromatography, High Pressure Liquid; Drug Combinations; Drug Stability; Salicylic Acid | 2009 |
Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Gels; Humans; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2009 |
Enhanced topical delivery and ex vivo anti-inflammatory activity from a betamethasone dipropionate formulation containing fish oil.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Cyclooxygenase 2; Dinoprostone; Drug Therapy, Combination; Fish Oils; Models, Animal; Salicylic Acid; Skin; Skin Absorption; Swine | 2010 |
Linear IgA bullous dermatosis of childhood: successful treatment with miocamycin and topical corticosteroid.
Topics: Anti-Bacterial Agents; Autoimmune Diseases; Betamethasone; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulin A; Infant; Male; Miocamycin; Skin Diseases, Vesiculobullous | 2009 |
Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Archaea; Betamethasone; Biocompatible Materials; Diffusion; Drug Carriers; Drug Delivery Systems; Halobacterium salinarum; Lipids; Liposomes; Materials Testing; Molecular Structure; Rheology; Shear Strength; Skin; Skin Absorption; Swine | 2010 |
Response of ulcerated necrobiosis lipoidica to clofazimine.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Clofazimine; Female; Humans; Immunosuppressive Agents; Necrobiosis Lipoidica; Stockings, Compression; Tacrolimus | 2009 |
Topical steroid is effective for the treatment of phimosis in young children.
Topics: Administration, Topical; Analysis of Variance; Anti-Inflammatory Agents; Betamethasone; Child; Child, Preschool; Humans; Infant; Male; Phimosis; Treatment Outcome | 2010 |
Two cases of annular elastolytic giant cell granuloma: Different response to the treatment.
Topics: Aged; Anti-Inflammatory Agents; Betamethasone; Cyclosporine; Female; Granuloma Annulare; Granuloma, Giant Cell; Humans; Hydroxychloroquine; Male; PUVA Therapy | 2010 |
[Topical steroids in the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab].
Topics: Adenocarcinoma; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Betamethasone; Cetuximab; Colonic Neoplasms; ErbB Receptors; Female; Humans; Middle Aged; Neoplasm Proteins; Paronychia | 2010 |
Circulating Th17 cell fluctuation in psoriatic patients treated with topical calcipotriol and betamethasone butyrate propionate.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Psoriasis; Th17 Cells; Treatment Outcome | 2011 |
Case of pretibial pruritic papular dermatitis. Letters to the editor.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Female; Humans; Leg Dermatoses; Pruritus; Skin Diseases, Papulosquamous | 2010 |
Development and validation of a stability-indicating RP-HPLC method for simultaneous assay of betamethasone dipropionate, chlorocresol, and for the estimation of betamethasone dipropionate related compounds in a pharmaceutical cream and ointment.
Topics: Betamethasone; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Cresols; Drug Stability; Linear Models; Ointments; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Stealth-nanoparticle strategy for enhancing the efficacy of steroids in mice with noise-induced hearing loss.
Topics: Animals; Betamethasone; Cochlea; Hair Cells, Auditory; Hearing Loss, Noise-Induced; Immunohistochemistry; Lactic Acid; Liver; Male; Mice; Nanoparticles; Polyesters; Polyethylene Glycols; Polymers; Receptors, Glucocorticoid; Rhodamines; Steroids | 2010 |
The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Drug Combinations; Humans; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2011 |
In vivo response of GsdmA3Dfl/+ mice to topically applied anti-psoriatic agents: effects on epidermal thickness, as determined by optical coherence tomography and H&E staining.
Topics: Animals; Anti-Inflammatory Agents; Betamethasone; Disease Models, Animal; Drug Therapy, Combination; Epidermis; Fish Oils; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Mutant Strains; Proteins; Psoriasis; Salicylic Acid; Staining and Labeling; Tomography, Optical Coherence; Treatment Outcome | 2011 |
Liposome surface charge influence on skin penetration behaviour.
Topics: Administration, Cutaneous; Animals; Betamethasone; Diffusion; Drug Carriers; Drug Delivery Systems; Drug Stability; Glucocorticoids; Liposomes; Osmolar Concentration; Particle Size; Skin; Skin Absorption; Surface Properties; Swine | 2011 |
A case of autoimmune progesterone dermatitis diagnosed by progesterone pessary.
Topics: Adult; Anti-Inflammatory Agents; Autoimmune Diseases; Betamethasone; Dermatitis; Drug Eruptions; Female; Humans; Luteal Phase; Pessaries; Pregnancy; Pregnancy Complications; Progesterone | 2011 |
In vitro evaluation of betamethasone esters for phototoxic potential.
Topics: Animals; Betamethasone; Betamethasone Valerate; Darkness; Dermatitis, Phototoxic; Erythrocytes; Free Radical Scavengers; Free Radicals; Glucocorticoids; Hemolysis; Mice; Singlet Oxygen; Ultraviolet Rays | 2012 |
Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: a cross-sectional and longitudinal study.
Topics: Adult; Betamethasone; Calcitriol; Cross-Sectional Studies; Dermatologic Agents; Erythroid Cells; Female; Humans; Longitudinal Studies; Male; Middle Aged; Neutrophil Activation; Oxidative Stress; Photochemotherapy; Psoriasis; Ultraviolet Therapy | 2012 |
Use of a psoriasis plaque test in the development of a gel formulation of calcipotriol and betamethasone dipropionate for scalp psoriasis.
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Dermatologic Agents; Drug Combinations; Drug Compounding; Female; Gels; Humans; Male; Ointments; Psoriasis; Scalp; Treatment Outcome; Young Adult | 2013 |
Irreversible visual loss secondary to excessive topical steroid use in eczema.
Topics: Administration, Cutaneous; Betamethasone; Eczema; Glaucoma; Glaucoma, Open-Angle; Glucocorticoids; Humans; Male; Ocular Hypertension; Vision Disorders; Young Adult | 2011 |
Once-daily application of calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment for repigmentation of facial vitiligo.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Child; Child, Preschool; Dermatologic Agents; Drug Combinations; Face; Female; Humans; Male; Middle Aged; Ointments; Treatment Outcome; Vitiligo | 2011 |
Needle-knife incisional treatment of refractory esophagic caustic stenosis.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Burns, Chemical; Catheterization; Esophageal Stenosis; Humans; Male; Sodium Hydroxide | 2011 |
Linear psoriasis.
Topics: Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Diagnosis, Differential; Drug Combinations; Humans; Male; Psoriasis; Skin Diseases | 2012 |
A comparative study of childhood psoriasis and atopic dermatitis and greater understanding of the overlapping condition, psoriasis-dermatitis.
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Child; Child, Preschool; Dermatitis, Atopic; Dermatologic Agents; Diagnosis, Differential; Female; Humans; Infant; Male; Psoriasis; Ultraviolet Therapy | 2012 |
The effects of betamethasone dipropionate and fish oil on HaCaT proliferation and apoptosis.
Topics: Anti-Inflammatory Agents; Apoptosis; Betamethasone; Caspase 3; Cell Line; Cell Proliferation; Cyclooxygenase 2; Drug Therapy, Combination; Fish Oils; Humans; Inflammation; Keratinocytes | 2012 |
Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis.
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Gels; Humans; Psoriasis; Quality of Life; Scalp Dermatoses; Time Factors | 2012 |
Calcinosis cutis following contact with calcium chloride solution.
Topics: Anti-Inflammatory Agents; Betamethasone; Calcinosis; Calcium Chloride; Humans; Male; Middle Aged; Skin Diseases; Solutions | 2012 |
Development and validation of a discriminative dissolution test for betamethasone sodium phosphate and betamethasone dipropionate intramuscular injectable suspension.
Topics: Betamethasone; Chromatography, High Pressure Liquid; Injections, Intramuscular; Particle Size; Solubility | 2013 |
Whole field laser Doppler imaging of the microcirculation in psoriasis and clinically unaffected skin.
Topics: Aged; Betamethasone; Calcitriol; Dermatologic Agents; Female; Heart Rate; Humans; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Pilot Projects; Psoriasis; Skin; Treatment Outcome | 2014 |
[Photo quiz: Dermatomycosis].
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Dermatomycoses; Fungi; Humans; Morpholines; Ointments; Skin | 2013 |
[Pustular psoriasis localized to the genital region].
Topics: Adult; Betamethasone; Biopsy; Dermatomycoses; Desonide; Diagnostic Errors; Herpes Genitalis; Humans; Immunosuppressive Agents; Male; Penile Diseases; Propylene Glycol; Psoriasis; Recurrence | 2013 |
Cutaneous pseudolymphoma occurring after traumatic implantation of a foreign red pigment.
Topics: Adult; Betamethasone; Biopsy; Coloring Agents; Female; Forehead; Humans; Lacerations; Lymphoproliferative Disorders; Pseudolymphoma; Skin; Skin Diseases; Triamcinolone Acetonide | 2013 |
A case of eosinophilic cystitis in patients with abdominal pain, dysuria, genital skin hyperemia and slight toxocariasis.
Topics: Abdominal Pain; Albendazole; Anthelmintics; Betamethasone; Biopsy; Cystitis; Cystoscopy; Dysuria; Emergencies; Eosinophilia; Humans; Hyperemia; Male; Middle Aged; Recurrence; Toxocariasis | 2013 |
The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis.
Topics: Administration, Cutaneous; Animals; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Glucocorticoids; Humans; Psoriasis; Vitamin D | 2013 |
Topical corticosteroids and secondary adrenal insufficiency: a relationship in the shade.
Topics: Administration, Topical; Adrenal Insufficiency; Aged; Betamethasone; Glucocorticoids; Humans; Male; Substance Withdrawal Syndrome | 2013 |
Development and validation of RP HPLC method for determination of betamethasone dipropionate in gingival crevicular fluid.
Topics: Betamethasone; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Gingival Crevicular Fluid; Humans | 2013 |
Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study.
Topics: Adolescent; Adult; Aged; Betamethasone; Calcitriol; Drug Administration Schedule; Female; Gels; Humans; Male; Middle Aged; Ointments; Patient Satisfaction; Prospective Studies; Psoriasis; Quality of Life; Young Adult | 2014 |
Prescription size and adherence in the management of psoriasis: is the more, the better?
Topics: Administration, Cutaneous; Anti-Inflammatory Agents; Attitude of Health Personnel; Betamethasone; Calcitriol; Clobetasol; Dihydroxycholecalciferols; Dose-Response Relationship, Drug; Drug Prescriptions; Gels; Humans; Immunosuppressive Agents; Medication Adherence; Practice Patterns, Physicians'; Psoriasis | 2014 |
Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort.
Topics: Adolescent; Betamethasone; Calcitriol; Child; Child, Preschool; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Ointments; Prospective Studies; Psoriasis; Quality of Life; Treatment Outcome | 2014 |
Adrenal insufficiency as a result of long-term misuse of topical corticosteroids.
Topics: Administration, Cutaneous; Adrenal Insufficiency; Adult; Betamethasone; Chronic Disease; Cushing Syndrome; Dermatitis, Atopic; Glucocorticoids; Humans; Male; Psoriasis; Self Medication; Time Factors; Young Adult | 2014 |
Calcipotriene-betamethasone dipropionate topical suspension in the management of psoriasis: a status report on available data with an overview of practical clinical application.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Dermatologic Agents; Dermatology; Drug Combinations; Evidence-Based Medicine; Humans; Psoriasis; Suspensions; Treatment Outcome | 2014 |
Treatment of paediatric scalp psoriasis with calcipotriene/betamethasone dipropionate scalp formulation: effectiveness, safety and influence on children's quality of life in daily practice.
Topics: Administration, Cutaneous; Adolescent; Betamethasone; Calcitriol; Child; Child, Preschool; Drug Combinations; Female; Humans; Male; Prospective Studies; Psoriasis; Quality of Life; Scalp Dermatoses; Severity of Illness Index | 2015 |
[Pseudo-condylomatous neurodermatitis of the anal margin].
Topics: Administration, Topical; Anal Canal; Anti-Inflammatory Agents; Betamethasone; Humans; Male; Middle Aged; Neurodermatitis; Pruritus Ani | 2014 |
Balance of Treg versus T-effector cells during systemic treatment with adalimumab and topical treatment with calcipotriol-betamethasone dipropionate ointment.
Topics: Adalimumab; Administration, Topical; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betamethasone; Biopsy; Calcitriol; CD4-Positive T-Lymphocytes; Female; Forkhead Transcription Factors; Humans; Immunohistochemistry; Inflammation; Male; Middle Aged; Ointments; Psoriasis; Skin; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha | 2015 |
Evaluation of change in the skin concentration of tazarotene and betamethasone dipropionate based on drug-drug interaction for transdermal drug delivery in miniature pig.
Topics: Administration, Cutaneous; Animals; Betamethasone; Dermis; Drug Delivery Systems; Drug Interactions; Epidermis; Gels; Nicotinic Acids; Ointments; Skin; Swine; Swine, Miniature; Time Factors | 2015 |
[Comparative investigation of rheological characteristics of the original drug Triderm and its generics in the form of cream].
Topics: Betamethasone; Clotrimazole; Drugs, Generic; Excipients; Gentamicins; Humans; Rheology; Skin Cream; Viscosity | 2014 |
Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris.
Topics: Administration, Cutaneous; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Pruritus; Psoriasis; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Suspensions; Treatment Outcome | 2014 |
Calcipotriol/betamethasone dipropionate ointment compared with tacrolimus ointment for the treatment of erosive pustular dermatosis of the scalp: a split-lesion comparison.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Immunosuppressive Agents; Ointments; Scalp Dermatoses; Tacrolimus | 2015 |
Topical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Betamethasone; Cytokines; Female; Humans; Immune Tolerance; Immunosuppression Therapy; Immunotherapy; In Vitro Techniques; Langerhans Cells; Lymphocyte Culture Test, Mixed; Middle Aged; RNA, Messenger; Young Adult | 2015 |
Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52-week PRO-long study.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Child; Dermatologic Agents; Drug Combinations; Female; Gels; Humans; Male; Medication Adherence; Middle Aged; Ointments; Patient Satisfaction; Prospective Studies; Psoriasis; Quality of Life; Severity of Illness Index; Time Factors; Young Adult | 2015 |
Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
Topics: Adrenal Cortex Hormones; Betamethasone; Calcitriol; Cell Communication; Cell Differentiation; Cells, Cultured; Cytokines; Drug Therapy, Combination; Gene Expression Regulation; Humans; Immunologic Factors; Inflammation Mediators; Keratinocytes; Langerhans Cells; Phenotype; Psoriasis; Receptors, Calcitriol; Signal Transduction; Th17 Cells; Tissue Culture Techniques | 2016 |
Full spectrum and selected spectrum based multivariate calibration methods for simultaneous determination of betamethasone dipropionate, clotrimazole and benzyl alcohol: Development, validation and application on commercial dosage form.
Topics: Algorithms; Anesthetics, Local; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Benzyl Alcohol; Betamethasone; Calibration; Clotrimazole; Drug Combinations; Least-Squares Analysis; Neural Networks, Computer; Principal Component Analysis; Skin Cream; Spectrophotometry | 2016 |
Association of Borage Oil and Betamethasone Dipropionate in Lipid-Core Nanocapsules: Characterization, Photostability and In Vitro Irritation Test.
Topics: Betamethasone; gamma-Linolenic Acid; Nanoparticles; Onions; Plant Oils | 2016 |
[Intramuscular depot steroids : Possible treatment of postsurgical cystoid macula edema with steroid response?]
Topics: Betamethasone; Delayed-Action Preparations; Humans; Injections, Intramuscular; Lenses, Intraocular; Macular Edema; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Recurrence; Reoperation; Retinal Detachment; Tomography, Optical Coherence; Triamcinolone; Vitrectomy | 2017 |
Shiitake dermatitis.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Betamethasone; Dermatitis; Histamine Antagonists; Humans; Loratadine; Male; Raw Foods; Shiitake Mushrooms | 2017 |
Economic burden of psoriatic patients in Japan: Analysis from a single outpatient clinic.
Topics: Administration, Cutaneous; Administration, Topical; Adult; Aged; Ambulatory Care Facilities; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Betamethasone; Biological Products; Calcitriol; Cost of Illness; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Female; Glucocorticoids; Humans; Japan; Male; Middle Aged; Psoriasis; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
A rare presentation of meralgia paraesthetica in limb girdle muscular dystrophy.
Topics: Adult; Anesthetics, Local; Anti-Inflammatory Agents; Betamethasone; Electromyography; Female; Femoral Neuropathy; Humans; Muscular Dystrophies, Limb-Girdle; Nerve Block; Nerve Compression Syndromes; Neural Conduction; Prilocaine; Thigh; Treatment Outcome | 2018 |
Role of personalized medication training in improving efficacy and adherence to a topical therapy in psoriatic patients.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Humans; Linear Models; Male; Middle Aged; Patient Compliance; Patient Education as Topic; Patient Satisfaction; Psoriasis; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Young Adult | 2017 |
Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.
Topics: Adolescent; Adult; Aged; Anxiety; Betamethasone; Calcitriol; Depression; Dermatologic Agents; Female; Health Status; Health Surveys; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Psoriasis; Psychometrics; Quality of Life; Young Adult | 2017 |
Budget impact model in moderate-to-severe psoriasis vulgaris assessing effects of calcipotriene and betamethasone dipropionate foam on per-patient standard of care costs.
Topics: Betamethasone; Biological Products; Budgets; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Models, Econometric; Psoriasis; Severity of Illness Index; United States | 2017 |
Changes in interleukin-17A, macrophage-derived chemokine and adiponectin following treatment of psoriasis with calcipotriol plus betamethasone dipropionate aerosol foam: results from the PSO-ABLE study.
Topics: Adiponectin; Administration, Cutaneous; Aerosols; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemokine CCL22; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Interleukin-17; Male; Middle Aged; Psoriasis; Treatment Outcome | 2018 |
In vivo characterization of structural changes after topical application of glucocorticoids in healthy human skin.
Topics: Administration, Topical; Betamethasone; Clobetasol; Epidermis; Glucocorticoids; Humans; Keratinocytes; Petrolatum; Skin | 2017 |
Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study.
Topics: Administration, Cutaneous; Adult; Betamethasone; Betamethasone Valerate; Clobetasol; Dermatitis, Allergic Contact; Dermatologic Agents; Female; Humans; Hydrocortisone; Male; Methylprednisolone; Mometasone Furoate; Patch Tests; Predictive Value of Tests; Prednisolone; Prevalence; Prospective Studies; Spain | 2018 |
Low incidence of hypercalcemia following combined calcipotriol hydrate/betamethasone dipropionate ointment treatment in Japanese patients with severe psoriasis vulgaris.
Topics: Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Calcium; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Incidence; Japan; Male; Middle Aged; Ointments; Psoriasis; Severity of Illness Index; Treatment Outcome | 2018 |
A cost-effectiveness analysis of calcipotriol plus betamethasone dipropionate aerosol foam versus gel for the topical treatment of plaque psoriasis.
Topics: Aerosols; Betamethasone; Calcitriol; Cost-Benefit Analysis; Dermatologic Agents; Humans; Ointments; Psoriasis; Quality-Adjusted Life Years | 2018 |
Prospective, Observational, Non-Interventional, Multicentre Study on the Efficacy and Tolerability of a New Calcipotriol/Betamethasone Aerosol Foam (Enstilar®) in Patients with Plaque Psoriasis under Daily Practice Conditions.
Topics: Adult; Aerosols; Aged; Anti-Inflammatory Agents; Betamethasone; Body Surface Area; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Severity of Illness Index; Treatment Outcome | 2017 |
Cutaneous pseudolymphoma following quadrivalent human papillomavirus vaccination - a rare adverse event.
Topics: Adult; Betamethasone; Female; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Injections, Intralesional; Injections, Intramuscular; Magnetic Resonance Imaging; Papillomavirus Vaccines; Pseudolymphoma; Rare Diseases; Skin Diseases | 2018 |
Simultaneous HPLC Determination of Betamethasone Esters-Containing Mixtures: Analysis of Their Topical Preparations.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Esters; Limit of Detection; Preservatives, Pharmaceutical | 2018 |
Successful Treatment with Dupilumab in a Patient with Severe, Difficult to Treat Atopic Dermatitis: Beware of Symptomatic Adrenal Insufficiency due to Abrupt Discontinuation of Potent Topical Corticosteroids.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adrenal Insufficiency; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Betamethasone; Biomarkers; Dermatitis, Atopic; Drug Substitution; Humans; Hydrocortisone; Male; Middle Aged; Remission Induction; Severity of Illness Index; Treatment Outcome | 2018 |
Patient-Reported Satisfaction With the Fixed Combination Calcipotriene/Betamethasone Dipropionate Foam for Plaque Psoriasis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Psoriasis; Self Report; Treatment Outcome; Young Adult | 2018 |
Jessner-Kanof lymphocyte infiltration responded well to impulse intralesional corticosteroid.
Topics: Adrenal Cortex Hormones; Betamethasone; Biomarkers; Biopsy; Cell Movement; Erythema; Female; Humans; Injections, Intralesional; Lymphocytes; Nose; Phenotype; Remission Induction; Skin; Treatment Outcome; Young Adult | 2018 |
Development of Betamethasone Dipropionate-Loaded Nanostructured Lipid Carriers for Topical and Transdermal Delivery.
Topics: Administration, Cutaneous; Animals; Betamethasone; Drug Carriers; Drug Compounding; Lipids; Nanoparticles; Particle Size; Skin; Solubility; Surface-Active Agents; Transition Temperature | 2019 |
Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching-adjusted indirect comparison.
Topics: Acitretin; Administration, Cutaneous; Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Esters; Female; Fumarates; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Thalidomide; Treatment Outcome | 2019 |
Itch relief in patients with psoriasis: effectiveness of calcipotriol plus betamethasone dipropionate foam.
Topics: Administration, Cutaneous; Adult; Aged; Betamethasone; Calcitriol; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Combinations; Dyssomnias; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pruritus; Psoriasis; Quality of Life; Randomized Controlled Trials as Topic; Single-Blind Method; Visual Analog Scale | 2019 |
Validated Chromatographic Methods for Simultaneous Determination of Calcipotriol Monohydrate and Betamethasone Dipropionate in the Presence of Two Dosage Form Additives.
Topics: Betamethasone; Calcitriol; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Limit of Detection; Linear Models; Ointments; Reproducibility of Results | 2019 |
Severe allergic contact dermatitis caused by topical bufexamac requiring hospitalization.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Bufexamac; Chemotherapy, Adjuvant; Dermatitis, Allergic Contact; Edema; Erythema; Facial Dermatoses; Histamine Antagonists; Hospitalization; Humans; Methylprednisolone; Ointments | 2019 |
A Cost-utility Analysis of Calcipotriol/Betamethasone Dipropionate Aerosol Foam versus Ointment for the Topical Treatment of Psoriasis Vulgaris in Sweden.
Topics: Administration, Cutaneous; Aerosols; Betamethasone; Calcitriol; Clinical Decision-Making; Clinical Trials, Phase II as Topic; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Dermatologic Agents; Disease Progression; Drug Compounding; Drug Costs; Glucocorticoids; Humans; Models, Economic; Office Visits; Ointments; Phototherapy; Psoriasis; Quality of Life; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Sweden; Time Factors; Treatment Outcome | 2019 |
Necrobiosis lipoidica with superimposed pyoderma vegetans.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Betamethasone; Cephalexin; Female; Humans; Mupirocin; Necrobiosis Lipoidica; Pyoderma; Skin Diseases, Bacterial | 2019 |
Psoriasis and skin pain: real-life effectiveness of calcipotriol plus betamethasone dipropionate in aerosol foam formulation.
Topics: Administration, Topical; Adult; Aerosols; Aged; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Hand; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Threshold; Prospective Studies; Psoriasis; Severity of Illness Index; Young Adult | 2019 |
Influence of emulsifier concentration on partition behavior and chemical stability of betamethasone dipropionate in emulsion gels.
Topics: 1-Octanol; Anti-Inflammatory Agents; Betamethasone; Drug Stability; Emulsifying Agents; Emulsions; Ethylene Glycols; Gels; Hydrogen-Ion Concentration; Polysorbates; Water | 2019 |
Rapid onset of action of calcipotriol/betamethasone dipropionate cutaneous foam in psoriasis, even in patients with more severe disease.
Topics: Administration, Cutaneous; Betamethasone; Calcitriol; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Patient Compliance; Psoriasis; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2019 |
Development of a simple method for simultaneous determination of tazarotene and betamethasone dipropionate and their metabolites using LC-MS method and its application to dermatopharmacokinetic study.
Topics: Betamethasone; Cell Culture Techniques; Cell Line; Chromatography, Liquid; Humans; Limit of Detection; Linear Models; Mass Spectrometry; Models, Biological; Nicotinic Acids; Reproducibility of Results; Skin; Tissue Engineering | 2019 |
DoE-based development, physicochemical characterization, and pharmacological evaluation of a topical hydrogel containing betamethasone dipropionate microemulsion.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Cellulose; Chemistry, Physical; Drug Carriers; Edema; Emulsions; Hydrogels; Male; Mice; Particle Size; Rabbits; Rats; Rheology; Skin; Solubility; Surface Properties | 2019 |
Patient and Physician Satisfaction with Calcipotriol and Betamethasone Dipropionate Aerosol Foam in the Treatment of Plaque Psoriasis on the Body.
Topics: Aerosols; Anti-Inflammatory Agents; Betamethasone; Cross-Sectional Studies; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Personal Satisfaction; Psoriasis; Retrospective Studies | 2019 |
Cushing's syndrome due to interaction between topical betamethasone dipropionate and darunavir/cobicistat.
Topics: Betamethasone; Cobicistat; Cushing Syndrome; Darunavir; Humans | 2020 |
Adult vulvar Langerhans cell histiocytosis: a rare presentation.
Topics: Adult; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents; Betamethasone; Ciclopirox; Cladribine; Diabetes Insipidus; Female; Histiocytosis, Langerhans-Cell; Humans; Vulvar Diseases | 2020 |
Comparison of corticosteroid injection and ozone injection for relief of pain in chronic lateral epicondylitis.
Topics: Adrenal Cortex Hormones; Betamethasone; Chronic Disease; Chronic Pain; Drug Administration Schedule; Female; Humans; Injections, Intra-Articular; Male; Middle Aged; Ozone; Pain Management; Pain Measurement; Retrospective Studies; Tennis Elbow | 2019 |
Clinical effectiveness of ultrasound guided subacromial-subdeltoid bursa injection of botulinum toxin type A in hemiplegic shoulder pain: A retrospective cohort study.
Topics: Aged; Anti-Inflammatory Agents; Betamethasone; Botulinum Toxins, Type A; Bursa, Synovial; Case-Control Studies; Female; Hemiplegia; Humans; Injections, Intra-Articular; Male; Middle Aged; Neuromuscular Agents; Retrospective Studies; Shoulder Pain; Stroke; Treatment Outcome; Ultrasonography, Interventional | 2019 |
Digital ulcerative lichenoid dermatitis in a patient receiving anti-PD-1 therapy.
Topics: Administration, Cutaneous; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Betamethasone; Carcinoma, Squamous Cell; Drug Combinations; Gentamicins; Humans; Lichenoid Eruptions; Male; Mouth Neoplasms; Programmed Cell Death 1 Receptor; Skin; Skin Ulcer | 2019 |
Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
Topics: Administration, Cutaneous; Animals; Betamethasone; Calcitriol; Cytokines; Dermatologic Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Gene Expression Regulation; Glucocorticoids; Humans; Imiquimod; Mice; Ointments; Psoriasis; Skin; Th1 Cells; Th17 Cells | 2020 |
Cost per PASI-75 responder of calcipotriol plus betamethasone dipropionate cutaneous foam versus nonbiologic systemic therapies for the treatment of plaque psoriasis in seven European countries.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2021 |
[Linear cutaneous hypopigmentation and atrophy associated with intralesional steroid injection for carpal tunnel syndrome].
Topics: Atrophy; Betamethasone; Carpal Tunnel Syndrome; HIV Infections; Humans; Hypopigmentation; Injections; Injections, Intralesional; Male; Middle Aged; Skin Diseases | 2020 |
Pulsed dye laser as an adjunctive treatment for therapy-resistant pityriasis rubra pilaris.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Arm; Betamethasone; Drug Therapy, Combination; Face; Female; Humans; Isotretinoin; Lasers, Dye; Methotrexate; Pityriasis Rubra Pilaris; Skin; Treatment Outcome | 2020 |
A Case of Linear Cutaneous Lupus Erythematosus in a 55-Year-Old Woman.
Topics: Administration, Topical; Age Factors; Anti-Inflammatory Agents; Betamethasone; Exanthema; Female; Forearm; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Midwestern United States; Pruritus; Skin; Sunscreening Agents; Treatment Outcome | 2020 |
Two cases of refractory nail psoriasis successfully treated with calcipotriol plus betamethasone dipropionate gel.
Topics: Administration, Oral; Aged; Betamethasone; Calcitriol; Cyclosporine; Dermatologic Agents; Drug Combinations; Drug Resistance; Female; Gels; Humans; Male; Middle Aged; Nail Diseases; Ointments; Psoriasis; Severity of Illness Index; Thalidomide; Treatment Outcome | 2020 |
Treatment of nail psoriasis with calcipotriol/betamethasone dipropionate foam versus pulse dye laser: an unblinded, intra-patient, left-to-right prospective study.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Lasers, Dye; Prospective Studies; Psoriasis; Treatment Outcome | 2020 |
Association of Topical Corticosteroids With Reduced Vulvar Squamous Cell Carcinoma Recurrence in Patients With Vulvar Lichen Sclerosus.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Carcinoma in Situ; Carcinoma, Squamous Cell; Clobetasol; Desonide; Female; Humans; Hydrocortisone; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Vulvar Lichen Sclerosus; Vulvar Neoplasms | 2020 |
Middermal Elastolysis-A Possible End Stage of Granuloma Annulare.
Topics: Adult; Asymptomatic Diseases; Betamethasone; Biopsy; Cutis Laxa; Dermis; Female; Granuloma Annulare; Humans; Skin Cream; Treatment Outcome; Tretinoin | 2020 |
Tattoo-Associated Sarcoidosis.
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisone; Sarcoidosis; Tattooing | 2020 |
Patient satisfaction and efficacy of calcipotriol plus betamethasone dipropionate gel in plaque psoriasis patients with poor adherence.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Patient Satisfaction; Psoriasis; Treatment Outcome | 2020 |
Development and characterization of a human Th17-driven ex vivo skin inflammation model.
Topics: Anti-Inflammatory Agents; Antibodies; Betamethasone; CD28 Antigens; CD3 Complex; Cell Communication; Culture Media; Dermatitis; Humans; Interferon-gamma; Interleukin-15; Interleukin-17; Interleukin-22; Interleukins; Keratin-16; Keratinocytes; Lymphocyte Activation; Models, Biological; Phosphodiesterase 4 Inhibitors; S100 Calcium Binding Protein A7; Th17 Cells; Tumor Necrosis Factor-alpha | 2020 |
Grover's disease successfully treated with calcipotriene/betamethasone dipropionate ointment.
Topics: Acantholysis; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Ichthyosis; Ointments; Psoriasis | 2020 |
[Skin manifestations associated with the new coronavirus SARS-CoV-2 disease].
Topics: Anti-Inflammatory Agents; Antiviral Agents; Benzimidazoles; Betacoronavirus; Betamethasone; Causality; Coronavirus Infections; COVID-19; Drug Eruptions; Drug Therapy, Combination; Humans; Hydroxychloroquine; Lopinavir; Male; Middle Aged; Pandemics; Piperidines; Pneumonia, Viral; Prednisone; Ritonavir; SARS-CoV-2; Skin Diseases, Viral | 2020 |
Bullous pemphigoid in adolescence, a rare demographic.
Topics: Adolescent; Anti-Inflammatory Agents; Antibiotics, Antitubercular; Betamethasone; Female; Glucocorticoids; Humans; Methylprednisolone; Mycophenolic Acid; Pemphigoid, Bullous; Prednisone | 2021 |
Enstilar® (Calcipotriene and Betamethasone Dipropionate) Foam for Plaque Psoriasis in Adolescents Aged 12-17 Years.
Topics: Administration, Cutaneous; Adolescent; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Psoriasis; Treatment Outcome | 2020 |
Reply: Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matchi
Topics: Betamethasone; Calcitriol; Clobetasol; Humans; Nicotinic Acids; Psoriasis | 2020 |
Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adju
Topics: Betamethasone; Calcitriol; Clobetasol; Humans; Nicotinic Acids; Psoriasis | 2020 |
Hailey-Hailey disease treated successfully with calcipotriol plus betamethasone dipropionate aerosol foam: A case report.
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Pemphigus, Benign Familial; Psoriasis; Treatment Outcome | 2021 |
Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational Study.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents; Betamethasone; Dermatologic Agents; Drug Combinations; Erythema; Female; Humans; Male; Middle Aged; Nicotinic Acids; Pain; Prospective Studies; Pruritus; Psoriasis; Recurrence; Retreatment; Severity of Illness Index; Skin Cream | 2021 |
Efficacy of topical calcipotriol betamethasone dipropionate as a new adjuvant therapy to follicular unit extraction technique in treatment of stable vitiligo: clinical, dermoscopic and immunohistological study.
Topics: Betamethasone; Calcitriol; Combined Modality Therapy; Humans; Treatment Outcome; Ultraviolet Therapy; Vitiligo | 2021 |
Pyoderma gangrenosum associated with levamisole-adulterated cocaine in a c-ANCA positive patient.
Topics: Adrenal Cortex Hormones; Antibodies, Antineutrophil Cytoplasmic; Betamethasone; Chronic Disease; Cocaine-Related Disorders; Diagnosis, Differential; Drug Contamination; Female; Humans; Levamisole; Maxillary Sinusitis; Middle Aged; Prednisone; Pyoderma Gangrenosum | 2021 |
Simultaneous Estimation of Apremilast and Betamethasone Dipropionate in Microsponge-Based Topical Formulation using a Stability Indicating RP-HPLC Method: A Quality-by-Design Approach.
Topics: Betamethasone; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Thalidomide | 2021 |
Efficacy and safety of fixed-dose combination calcipotriol/betamethasone dipropionate foam for the treatment of psoriasis.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Psoriasis; Treatment Outcome | 2021 |
Fixed-dose combination calcipotriol/betamethasone dipropionate foam provides a rapid onset of action, effective itch relief and improves patient quality of life.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Quality of Life; Treatment Outcome | 2021 |
Early efficacy and safety data with fixed-dose combination calcipotriol/betamethasone dipropionate foam attributed to mechanism of absorption and steroid potency.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Psoriasis; Treatment Outcome | 2021 |
Calcipotriol/betamethasone dipropionate foam demonstrates comparable efficacy to clinical trial data in the real world, improves patient satisfaction and is cost-effective.
Topics: Betamethasone; Calcitriol; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Germany; Humans; Patient Satisfaction; Psoriasis; Quality of Life; Spain; Treatment Outcome | 2021 |
Editorial: fixed-dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Ointments; Psoriasis; Treatment Outcome | 2021 |
Topical calcipotriol plus betamethasone dipropionate for the treatment of plaque psoriasis: a drug evaluation.
Topics: Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Drug Evaluation; Humans; Psoriasis; Treatment Outcome | 2021 |
Systemic allergic dermatitis during tetracaine hydrochloride patch testing.
Topics: Aged, 80 and over; Anesthetics, Local; Anti-Inflammatory Agents; Betamethasone; Dermatitis, Allergic Contact; Diagnosis, Differential; Female; Humans; Patch Tests; Tetracaine | 2021 |
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real-life multicenter prospective observational cohort study.
Topics: Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Psoriasis; Treatment Outcome | 2021 |
Development and validation of a RP-UPLC method for the determination of betamethasone dipropionate impurities in topical formulations using a multivariate central composite design.
Topics: Betamethasone; Chromatography, High Pressure Liquid; Limit of Detection; Reproducibility of Results | 2021 |
Calcipotriene Plus Betamethasone Dipropionate Foam for Mild Psoriasis: Pooled Results from Three Randomized Trials.
Topics: Betamethasone; Calcitriol; Dermatologic Agents; Dosage Forms; Drug Combinations; Humans; Prospective Studies; Psoriasis; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Erythema Elevatum Diutinum Appearing Within Old Scar Tissue.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Betamethasone; Biopsy; Cicatrix; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Ointments; Prednisolone; Skin; Treatment Outcome; Vasculitis, Leukocytoclastic, Cutaneous | 2021 |
The continued inappropriate use and overuse of combination topical clotrimazole-betamethasone.
Topics: Adolescent; Adult; Antifungal Agents; Betamethasone; Child; Clotrimazole; Drug Combinations; Female; Glucocorticoids; Humans; Logistic Models; Male; Mycoses; Prescription Drug Overuse; Retrospective Studies | 2021 |
Adjunctive Use of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Patients With Psoriasis Treated With Ixekizumab.
Topics: Adult; Antibodies, Monoclonal, Humanized; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Middle Aged; Prospective Studies; Psoriasis; Treatment Outcome | 2022 |
The Maintenance Effect of Calcipotriene 0.05% and Betamethasone Dipropionate 0.064% (Cal/BD) Aerosol Foam in Combination With Apremilast.
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Pilot Projects; Psoriasis; Thalidomide; Treatment Outcome | 2022 |
Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach.
Topics: Aerosols; Betamethasone; Consensus; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Recurrence; Treatment Outcome | 2022 |
The effect of dilution of fusidic acid cream and betamethasone dipropionate cream in complex extemporaneous mixes on formulation performance.
Topics: Administration, Topical; Betamethasone; Emollients; Fusidic Acid; Staphylococcus aureus | 2022 |
Betamethasone Dipropionate Nanocrystals: Investigation, Feasibility and In Vitro Evaluation.
Topics: Administration, Cutaneous; Betamethasone; Excipients; Feasibility Studies; Nanogels; Nanoparticles; Particle Size; Skin | 2022 |
Betamethasone Dipropionate Derivatization, Biotransformation, Molecular Docking, and ADME Analysis as Glucocorticoid Receptor.
Topics: Betamethasone; Biotransformation; Dermatologic Agents; Humans; Molecular Docking Simulation; Psoriasis; Receptors, Glucocorticoid | 2022 |
The Effect of the Long-Term Calcipotriol/Betamethasone Dipropionate Local Therapy on Tissue Resident Memory Cells Markers in Psoriatic Eruptions.
Topics: Betamethasone; Calcitriol; Humans; Immunologic Memory; Interleukin-17; Psoriasis; Recurrence | 2022 |
An anchored matching-adjusted indirect comparison of fixed-dose combination calcipotriol and betamethasone dipropionate (Cal/BDP) cream versus Cal/BDP foam for the treatment of psoriasis.
Topics: Aerosols; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2022 |
Annual trends in Medicare part D prescription claims for calcipotriene/betamethasone dipropionate foam for psoriasis 2016-2020.
Topics: Aged; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Medicare Part D; Psoriasis; Treatment Outcome; United States | 2023 |
Real-world efficacy of adjunctive calcipotriene/betamethasone dipropionate foam for recalcitrant psoriatic lesions on the scalp or lower legs with biologic therapy.
Topics: Betamethasone; Biological Products; Biological Therapy; Dermatologic Agents; Drug Combinations; Humans; Leg; Psoriasis; Retrospective Studies; Scalp; Treatment Outcome | 2023 |
INDIVIDUAL ARTICLE: Vehicles Matter: Calcipotriene and Betamethasone Dipropionate Foam as a Topical Psoriasis Therapy.
Topics: Aerosols; Betamethasone; Dermatologic Agents; Drug Combinations; Humans; Psoriasis; Treatment Outcome | 2023 |